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Cognitive tests are typically scored and interpreted using an appropriate normative 
reference group, often similar age individuals with similar levels of education. 
Psychometric testing theory presupposes that demographic correction is always 
beneficial, supporting the ubiquitous use of age and education correction in clinical 
practice. In the context of dementia, however, there is some evidence suggesting that 
demographic correction (specifically age correction) may reduce the sensitivity of 
cognitive tests to age related cognitive decline. It was hypothesized that age correction 
would reduce the utility of cognitive tests for detecting cognitive change in individuals 
with mild cognitive impairment and mild dementia due to Alzheimer’s disease. This 
hypothesis was investigated using the National Alzheimer’s Coordinating Center 
(NACC) database. NACC data are contributed by the NIA-funded Alzheimer’s Disease 
Centers (ADCs). A series of hierarchical multiple linear regressions predicted the CDR® 
Dementia Staging Instrument Sum of Boxes Score (CDR-SB) from domain specific 
composite scores derived using different types of demographic correction (i.e., no 
correction, age correction, education correction, and both age and education correction). 
When looking at memory scores alone, raw scores captured more variation in the CDR-
SB. However, when using a typical neuropsychological (NP) battery approach, correcting 
for education only produced a superior model. Findings may be used by clinicians for 
positive social change by recognizing that a diagnosis between normal cognitive aging 
and dementia is never determined by a single cut off score in clinical practice, correcting 
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Chapter 1: Introduction to the Study  
The overarching purpose of this study was to investigate the impact of 
demographic correction on the diagnostic validity of cognitive tests when differentiating 
between normal cognitive aging and dementia, because it was not clear how to best use 
normative data in dementia diagnostic evaluations. This goal was achieved by 
constructing a series of cognitive composite scores from tests subject to different types of 
demographic correction (i.e., uncorrected test scores, age corrected test scores, education 
corrected test scores, as well as age and education corrected test scores) and examining 
their relationship with a gold-standard measure used to determine the presence or absence 
of dementia, the CDR-SB.  
The fields of education and psychology recognize standardized testing and norm-
referenced scoring as a significant method of collecting meaningful information about 
individuals and groups. The American Educational Research Association (AERA) in a 
joint committee with the American Psychological Association (APA) and the National 
Council on Measurement in Education (NCME) asserted, “Educational and psychological 
testing and assessment are among the most important contributions of cognitive and 
behavioral sciences to our society” arguing that better decisions are made with their 
proper use (AERA, APA & NCME, 2014, p.1). Psychological testing plays a big part in 
the diagnosis of dementia, a progressive cognitive decline that is serious enough to take 
away a person’s independence. Since more people are surviving into old age, the period 
of highest risk for cognitive deficits related to dementia, the number of people that can be 
helped using a NP measurement perspective is increasing.  
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It is imperative to diagnose the condition early and with accuracy, as by the time 
clinical symptoms are clear enough to make a definitive diagnosis, too many neurons 
have already been destroyed and the damage is irreversible. There is a need to gain 
empirical characterizations of normal cognitive aging, mild cognitive impairment (MCI), 
and dementia using comprehensive NP methods (Bondi et al., 2014). Standardized testing 
using normative methods provides a comprehensive assessment of general cognitive 
functioning that identifies strengths and weaknesses in examinees with a variety of 
neurological conditions. While brief global cognitive assessment screening measures like 
the Montreal Cognitive Assessment (MoCA) and the Mini-Mental State Examination 
(MMSE) are used to delineate between healthy aging and dementia using cut off scores, 
they are limited in their sensitivity to cognitive impairment and do not reliably 
differentiate normal from diseased individuals until late in the course of the illness 
(Malek-Ahmadi et al., 2015; Roalf et al., 2013; Stephan et al., 2017).  
Psychometric theory has long recognized that the individual’s performance on 
standardized tests is strongly related to demographic variables such as age and education. 
For example, an 80-year-old man with 8 years of education cannot be expected to achieve 
the same memory performance as a 30-year-old with 20 years of education. Clearly, 
comparing the elderly individual’s performance to that of the 20-year-old in this scenario 
would be inappropriate. Rather, cognitive testing is typically interpreted using 
demographically corrected scores that allow an “apples to apples” comparison. In the 
example above, the 80-year-old man’s performance would be demographically corrected 
by comparing his performance to other similar aged individuals with similar levels of 
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education. Therefore, it is standard practice to demographically correct test scores for age 
and education to increase their sensitivity to detecting impairments and facilitate test 
score comparison to an appropriate normative cohort (Heaton et al., 2004; Malek-Ahmadi 
et al., 2015; Petersen et al., 2014; Quaranta et al., 2016; Smith & Bondi, 2013). In certain 
cases, demographic correction may enhance sensitivity to cognitive changes. For 
example, if the 20-year-old in the example above is compared to other young, highly 
educated individuals, then the stringent expectations placed on his performance are more 
likely to reveal a change has occurred (Heaton et al., 2004; Malek-Ahmadi et al., 2015; 
Quaranta et al., 2016; Schoenberg & Scott, 2011). 
The current debate is whether the use of a normative system universally 
 improves diagnostic accuracy in an aging population. Researchers argue that current 
norms may underestimate the presence of cognitive impairments in the older population 
because the norms are contaminated with undiagnosed cognitively impaired individuals 
(Hassenstab et al., 2016; Hessler et al., 2014; O’Connell & Tuokko, 2010). If individuals 
with undiagnosed impairments are present in “normal samples” of healthy elderly, then 
this decreases the performance expectations for the group as a whole and increases 
variability, thus obscuring the detection of change (Hassenstab et al., 2016; Hessler et al., 
2014; O’Connell & Tuokko, 2010). Considering that the base rate of dementia becomes 
incredibly high, around 40% over age 80 (Alzheimer’s Association [AA], 2018) this is a 
serious problem for NP research. A limited number of studies suggested that raw test 
scores or education-only test scores may be more sensitive to impairment (Hassenstab et 
al., 2016; Hessler et al., 2014; O’Connell & Tuokko, 2010). The use of partially corrected 
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and uncorrected test scores has not been rigorously empirically evaluated, and further 
research on this topic is justified (Smith & Bondi, 2013).  
It is imperative to continually monitor changes and revise key documents in this 
rapidly evolving field to develop the utility of this body of knowledge (AERA, APA & 
NCME, 2014; Smith & Bondi, 2013). When a rival hypothesis challenges the status quo, 
the validation process must continue to obtain empirical evidence by conducting a logical 
analysis that evaluates the new proposition. Outcome studies using comprehensive NP 
testing to reveal the patterns and profiles of cognitive dysfunction are critically needed to 
move the field significantly forward (Bondi et al., 2014; Malek-Ahmadi et al., 2015; 
Smith & Bondi, 2013). Important contributions can be made to the field if the findings of 
this investigation support that one set of scores (a) raw scores, (b) scores that are only age 
corrected, (c) scores that are only education corrected, or (d) a combination of age and 
education correction demonstrate better predictive power of the patient’s dementia 
severity as measured by the CDR-SB. This study addressed the specific need to 
differentiate normal aging and dementia using cognitive testing and various combinations 
of demographic corrections (normative data) to examine the strength of the test scores’ 
relationship to the patient’s clinical status. 
Problem Statement 
The rapid growth of our oldest population, referred to as the “silver tsunami”, will 
cause an unprecedented challenge to our health care industry, namely our Medicare 
system (AA, 2018; Gill, 2015; He et al., 2016). Because age is the number one risk factor 
for cognitive impairment due to Alzheimer’s disease (AD) and other types of dementia, 
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the natural increase in dementia cases will create historically high financial demands for 
medical expenses and ongoing personal care needs (AA, 2018; Gill, 2015; Smith & 
Bondi, 2013). It is estimated that costs will exceed $47 trillion for medical and long-term 
care expenses for all the individuals in the United States alive today that will develop 
dementia (AA, 2018, Zissimopoulos et al., 2014). Researchers are in search of a set of 
predictors to differentiate those who are experiencing normal cognitive decline due to 
aging from individuals who are in the process of developing dementia, an irreversible 
neurodegenerative process. NP methods may be ideal for that purpose.  
Significant medical, emotional, and social benefits for both the individual and 
their families will result from our ability to differentiate between normal aging, MCI, and 
dementia earlier and more accurately. The presumed benefit to identifying cognitive 
impairment earlier is that cognitively impaired individuals are at higher-than-average risk 
of transitioning into dementia (AA, 2018; Dubois et al., 2016; Hessler et al., 2014; Langa 
& Levine, 2014; Petersen et al., 1999; Smith & Bondi, 2013). Diagnostic accuracy of 
early dementia is critical because secondary prevention trials, disease-modifying 
treatments, need to be administered early in the disease process before too much damage 
has been done (AA, 2018; Dubois et al., 2016; Rockwood et al., 2014; Smith & Bondi, 
2013; Sperling et al., 2011; Ward et al., 2013; Zissmopoulos et al., 2014).  
There is no single universally accepted test for dementia. A differential diagnosis 
requires a thorough workup that includes laboratory, structural neuroimaging, neurologic 
and clinical information. In alignment with psychometric theory, it is widely recognized 
that an individual’s performance on standardized tests is strongly related to demographic 
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variables such as age, education, sex, and ethnicity, therefore raw scores are “corrected” 
to increase the test’s sensitivity to impairment (Heaton et al.; 2004; Malek-Ahmadi et al., 
2015; Quaranta et al., 2016; Schoenberg & Scott, 2011;). However, there is a lack of 
empirical evidence that these demographic corrections improve cognitive testing’s 
accuracy in late adulthood.  
Researchers now question whether the demographically corrected normative 
system universally improves diagnostic accuracy (Hassenstab et al., 2016; Hessler et al., 
2014; Holtzer et al, 2008; O’Connell & Tuokko, 2010). The current study was an 
outcome study that examined the relationship between the tests, normed different ways, 
and the dementia diagnostic status, with the goal of finding which way of scoring best 
captured the real-world changes associated with dementia. Because demographic 
corrections had not been rigorously empirically evaluated in late adulthood, further 
research into this area was warranted to determine if raw test scores may demonstrate 
superior sensitivity for differentiating between normal aging and dementia.   
Purpose 
The purpose of this quantitative study was to identify optimal normative methods 
for detecting pathologic cognitive change in elderly individuals. This was achieved by 
examining the manner in which demographic corrections for age alone, education alone, 
and age and education together affected the relationship between the NP test scores and a 
patient’s clinical dementia severity as measured by the CDR-SB. Individuals with normal 
cognition, mild cognitive impairment (i.e., predementia, and mild dementia due to AD 
served as the study population. Analyses proceeded in three steps. First, tests were scored 
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using four different methods of demographic correction (i.e., no correction, age 
correction, education correction, age and education correction). This yielded four 
different sets of test scores. Second, test scores were aggregated into cognitive composite 
scores (i.e., one set of composite scores per norming method). Finally, the relationship of 
each set of cognitive composite scores to dementia severity status was analyzed using 
four different hierarchical linear regressions to determine which normative method 
captured the most variance associated with the cognitive changes that accompany 
dementia. The R2 values from these different regressions were compared across the 
different norming methods to identify which method of demographic correction was most 
strongly associated with the dementia severity status. Akaike’s Information Criterion 
(AIC) was calculated and evaluated using published cutoffs frequently used to compare 
non-nested models (Burnham & Anderson, 2004).  
 Multiple regression was ideally suited for this task given that it is explicitly 
designed for examining the magnitude of association between a set of continuous 
predictor variables and a continuous outcome variable (Field, 2013). In this study, 
composite scores derived from tests scored using four different methods of normative 
correction served as the continuous predictor variables in four different hierarchical linear 
regressions (i.e., one for each norming method) modeling the CDR-SB, a gold-standard 
measure of the extent to which cognitive loss interferes with an individual’s real-world 
functioning ([dementia status]; Burke et al., 1988). As above, the R2 values and AIC 
values from the different regressions were compared across norming methods, to 
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determine which method best captured functional decline due to cognitive impairment in 
MCI and AD dementia. 
Because the order of entry into a hierarchical linear regression model greatly 
impacts the results, the order of entry was defined a priori, based on prior work. This 
facilitated comparability across models. It was hypothesized that memory and executive 
function would be most strongly related to dementia severity status, followed by 
language and attention function. Impairments in memory and executive functioning have 
been established as prototypical early changes in presentations of AD (Karantzoulis & 
Galvin, 2011). It was also predicted that age-adjustment would decrease the magnitude of 
the association between cognitive test scores and the CDR-SB while education-
adjustment would increase the magnitude of association between cognitive test scores 
and the CDR-SB. The findings of this study may aid in determining how to best use 
normative data in dementia diagnostic evaluations, identify specific and increase the 
understanding of cognitive biomarkers in a specific neurodegenerative disease.  
Significance 
Malek-Ahmadi et al., (2015) asserted that classification of impairment using 
normative data that corresponds with a specific clinical diagnosis is needed to further the 
field. Mortamais et al. (2017) argued that secondary prevention trials are hindered by a 
lack of proximal cognitive outcome markers. The results of this study may advance the 
understanding of the issues raised by these researchers. This project was unique because 
it is assumed that we should use age- and education-corrected scores in standardized 
testing, but it has not been rigorously empirically evaluated in our aging population 
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(Quaranta et al., 2016). Previous researchers who have examined the impact of age and 
education corrected scoring focused either on a single test score (Sliwinski et al.,1996; 
Sliwinski et al., 1997), or used heterogeneous composite scores that represented multiple 
cognitive domains (Hessler et al., 2014). One novel feature of this study was the creation 
of domain-specific cognitive scores for (a) memory, (b) executive function, (c) language, 
and (d) attention. This allowed for the precise investigation of the extent to which age and 
education correction affected the predictive validity of these individual cognitive 
domains. This is important because it is unlikely that cognitive domains are affected by 
demographic variables in a uniform manner. For example, we know that processing speed 
declines with age (Eckert, 2010) but crystallized intelligence such as vocabulary and 
knowledge remain relatively stable and may even improve during senescence (Harada et 
al., 2013). It stood to reason that age correction might enhance the accuracy with which 
changes in processing speed could be detected across the lifespan and is less important 
when measuring crystallized knowledge. No studies could be located that examined the 
relationship between dementia severity and demographically corrected cognitive test 
scores at an individual domain level.  
Positive social change results from improvements that promote earlier detection 
of neurodegenerative diseases allowing for better treatment planning and prediction of 
progression into dementia. The ability to delay the progression of dementia, even just for 
1 year, is shown to have significant medical, emotional, and social benefits for the 
individual, as well as financial benefits for our nation. Opening this window to earlier 
interventions gives the individual more time to seek treatment, learn compensatory 
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strategies, and participate in their own care and estate planning. This has the potential to 
save money on the historically-costly long course of this disease (AA, 2018; Dubois et 
al., 2016; Langa & Levine, 2014; Zissimopoulos et al., 2014).  
Background 
Francis Galton was credited with launching the modern psychological testing 
movement using systematic data he collected on different psychological processes in 
1884; not only did he pioneer tests of sensory discrimination, but he also developed the 
use of self-report measures (rating scales) along with the statistical methods necessary for 
analysis of the data (Anastasi & Urbina, 1997). After a chance meeting with an American 
psychologist, James McKean Cattell, a former student of Wilhelm Wundt, Cattell merged 
Galton’s new testing movement with what he learned in Wundt’s experimental laboratory 
in Leipzig, Germany. Cattell continued his work during his tenure at the University of 
Pennsylvania and furthered psychological testing when he proposed a series of 10 
different tests and measurements to explore the “constancy”, “interdependence”, and 
“variations of mental processes” (Cattell, 1890). Cattell also sketched out rudimentary 
methodology for standardized administration in an effort to gain the uniform results 
necessary to enable comparisons across different times and places. Cattell’s work helped 
spread the interest in quantifying mental abilities to further psychology as a science.  
 The next hundred years in psychological testing research saw huge leaps forward 
with an understanding of measurement error, validation studies, and the development of 
norms for different populations (Cortina et al., 2017). Alfred Binet created the first 
comprehensive standardized test in 1904 to determine how students would achieve in a 
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classroom, and along with his advance came the development of norm-referenced scoring 
to estimate the position of the individual within the context of a larger population. In 
other words, was the person’s performance “normal” for students of the same age, and by 
comparing students to each other he determined if a particular student was ahead-of or 
behind the “norm” (Binet & Simon, 1980). Researchers eagerly adopted these statistical 
significance and prediction models that emphasized psychometric properties and 
classification, and an explosion of new measures and data-analysis innovations were 
developed (Cortina et al., 2017).  
The use of testing in the field of neuropsychology began around WWII when the 
assessment and recovery of brain injured soldiers created a new need in the field of 
testing beyond the sensory, vocational, and intelligence testing that was currently 
available. Ralph Reitan, a recent college graduate, was given the task of evaluating brain-
injured soldiers and found a lack of publications available for reference (Grant & Heaton, 
2015). The profiles and patterns that were revealed by NP testing became a key 
component in making a differential diagnosis, predicting the progression of, and planning 
the treatment for neurodegenerative diseases. This research consistently demonstrated 
that actuarial methods were a necessary component for comprehensive assessment 
(Heaton et al., 2004; Quaranta et al., 2016; Ritchie, et al., 2015; Smith & Bondi, 2013; 
Sutphen et al., 2015). The use of a normative system in NP testing, with its roots in the 
work of pioneer Alfred Binet, has since been assumed to provide more refined estimates 
of cognitive performance and better detection of cognitive impairments (Heaton et al., 
2004; Malek-Ahmadi et al., 2015).  
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Normative scores are derived from the performance of a large, diverse normative 
sample that demographically represents the U.S. population. Yet some researchers have 
argued that despite their attempt at representativeness, it may be advantageous to develop 
norms based on specific subgroups and subpopulations to improve the utility of testing 
(Brown & Bryant, 1984; Chew et al., 1984; Hassenstab et al., 2016; Holtzer et al., 2008; 
Oosterhuis et al., 2016; Svinicki & Tombari, 1981). The aging population may be one 
specific subgroup that warrants the use of an alternative method because of the presence 
of undiagnosed cognitive impairments in the normative reference population. Researchers 
forwarded a proposal that demographic corrections may not improve diagnostic accuracy 
in the service of diagnosing cognitive impairment in an older population because the 
norms are tainted with individuals who may be in early stages of a degenerative cognitive 
decline, which compromises the mean performance and increases the variability in the 
normative sample (Hassenstab et al., 2016; Hessler et al., 2014; Holtzer et al., 2008; 
O’Connell & Tuokko, 2010; Wyman-Chick et al., 2018). Yet other researchers like 
Quaranta et al. (2016) failed to support the hypothesis that raw scores were superior to 
age-corrected scores and normative scoring remains standard practice. Wyman-Chick et 
al. (2018) argued that the selection of the normative comparison group greatly impacts 
both research and clinical interpretations of cognitive data. Yet no studies could provide 
rigorously validated impact of demographic corrections on the diagnostic accuracy of 
cognitive testing in individual cognitive domains when employed in dementia diagnostic 
evaluations. The current study focused on the accuracy of raw scores versus 
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demographically corrected scores using an outcome study with a large data set gathered 
through the NACC database.  
Framework 
This study was grounded in testing and measurement theory that governs how 
psychological constructs are measured and compared between individuals and groups. 
Professor James McKean Cattell (1890) at the University of Pennsylvania wrote about 
the benefits of standardized psychological testing, arguing that efforts:   
Would be of considerable scientific value in discovering the 
constancy of mental processes, their interdependence, and their 
variation under different circumstances…the scientific and 
practical value of such tests would be much increased should a 
uniform system be adopted, so that determination made at different 
times and places could be compared and combined. (p. 347) 
Frenchman Alfred Binet furthered the utility of testing and measurement in an 
educational setting when he developed the first comprehensive standardized test in 1904 
as a method of classifying which students could or could not achieve in the classroom. 
Binet never claimed that his scale could measure intelligence like a “ruler can measure a 
linear surface”, but instead he claimed to provide “…a classification, a hierarchy among 
diverse intelligences; and for the necessities of practice this classification is equivalent to 
a measure” (Binet & Simon, 1980, p. 41). Binet developed what is now known as norm-
referenced scoring to allow an estimation of the individual’s position within the context 
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of a larger population. Thus, norms became a fact of life in educational and psychological 
assessment.  
It was quickly realized that much of variance between test scores could be 
accounted for by a single demographic variable, and mounting evidence over the 
evolution of standardized testing showed that even more variances could be accounted for 
with a combination of multiple demographic variables (Barona et al., 1984; Karzmark et 
al., 1985; Wilson et al., 1978). The addition of demographic corrections became almost 
mandatory in psychological testing because these factors are relevant in an individual’s 
diagnosis (Quaranta et al., 2016). In 2004, Heaton et al. published a widely adopted 
comprehensive set of demographically adjusted NP norms for more than 50 commonly 
used measure for adults ages 20- to 85-years old which helped solidify the use of a 
normative system in the field of NP testing at all ages.  
Using the established framework, the predictor variables, the demographically 
corrected scores, should better predict the outcome variable (the dementia severity rating 
as measured by the CDR-SB) because demographically corrected scores are believed to 
improve diagnostic accuracy. But researchers argue different reasons that this may not be 
true. Manuals for standardized testing give national norms, but the utility of norms is 
questioned in an aging demographic. First and foremost, individuals in the normative 
sample population may already be transitioning into dementia and contaminating the 
norms by lowering the mean performance and increasing the variability in cross-sectional 
normative samples (Hassenstab et al., 2016; Hessler et al., 2014; O’Connell & Tuokko, 
2010). Similarly, many individuals in an aging normative sample may be prescribed brain 
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impairing maintenance medications that also affect their performance and increase the 
variability within the sample. Second, is the Flynn effect; norms become less accurate 
when too much time passes since publication due to changes in demographics, 
socioeconomics, and cultural factors that modify the reference population. Third, norms 
become more forgiving and tolerant of errors as age increases, possibly underestimating 
the risk of dementia in our oldest population. The current study hypothesized that age-
corrected scores would have the lowest magnitude of association with dementia severity 
level as measured by the CDR-SB, while education-corrected scores would have a higher 
magnitude of association with dementia severity level as measured by the CDR-SB. 
Research Questions 
The overarching research question was: how does demographic correction for age 
and education affect the relationship between cognitive tests and functional deterioration 
due to cognitive impairment? Some researchers proposed that raw test scores may have 
superior sensitivity for detecting cognitive changes accompanying dementia in an aging 
population, over the standard practice of demographically correcting the scores for age 
and education level (Hessler et al, 2014; Holtzer et al., 2008; O’Connell & Tuokko, 
2010). It is not clear how to best use normative data in dementia diagnostic evaluations 
using cognitive testing and there is no consensus in the literature making a rigorous 
empirical investigation using an outcome study warranted. Tests will be scored 4 
different ways (a) corrected for gender, age, and education (GEA); (b) corrected for 
gender and age (GA); (c) corrected for gender and education level (GE); and (d) raw test 
scores corrected for gender only (G). Cognitive composite scores representing memory 
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and learning, executive functioning, language, and attention were built for each norming 
method. Then one multiple linear regression equation per norming method (four total) 
was built. These models were then compared by examining the R2 and AIC values to 
determine which model “best” captured functional decline due to cognitive loss. The 
multiple linear regression equations outlined below were used to determine which set of 
scores had the strongest relationship with the patient’s clinically determined dementia 
severity level as measured by the CDR-SB. 
1. The relationship between the CDR-SB and cognitive composites built from 
GEA corrected data. 
2. The relationship between the CDR-SB and cognitive composites built from GA 
corrected data.  
3. The relationship between the CDR-SB and cognitive composites built from GE 
corrected data.  
4. The relationship between the CDR-SB and cognitive composites built from 
“raw” or G corrected test data. 
The novel feature of the current study was the creation of domain-specific cognitive 
composite scores. There were 4 steps to each regression equation because each composite 
score, memory, executive function, language, and attention, was entered into the equation 
in a hierarchical fashion allowing for the precise investigation of the extent to which the 




RQ1:  How do age and education correction affect the relationship between cognitive 
tests and functional deterioration due to cognitive impairment (i.e., dementia severity)?  
H1:  Age and education correction increase the extent to which NP tests capture 
functional decline due to cognitive loss in dementia. This will be tested by 
comparing R2 and AIC values from regression equation 1 with regression equation 
4. For example, if the R2 value in equation 1 is moderate (R2 > .25) and the R2 
value in equation 4 is strong (R2 > .4) as per conventions from Cohen (1988), then 
the null hypothesis can be rejected. Alternatively, if the AIC of model 4 is less 
than the AIC value of model 1 by 4 or more (Burnham & Anderson, 2016), then 
the null hypothesis can be rejected.  
H01:  Age and education correction decrease or have no effect on the extent to 
which NP tests are able to capture functional decline due to cognitive loss in 
dementia. 
Sub RQ2:  How does age correction affect the relationship between 
cognitive tests and functional deterioration due to cognitive impairment?    
H2:  Age correction decreases the extent to which NP tests are able to 
capture functional decline due to cognitive loss in dementia. This will be 
tested by comparing R2 and AIC values from regression equation 4 with 
regression equation 2. For example, if the R2 value in equation 2 is 
moderate and the R2 value in equation 4 is strong, then the null hypothesis 
can be rejected. Alternatively, if the AIC of model 4 is less than the AIC 
value of model 2 by 4 or more, then the null hypothesis can be rejected.  
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H02:  Age correction increases or has no effect on the extent to which NP 
tests are able to capture functional decline due to cognitive loss in 
dementia. 
Sub RQ3:  How does education correction affect the relationship between 
cognitive tests and functional deterioration due to cognitive impairment?    
H3:  Education correction increases the extent to which NP tests are able to 
capture functional decline due to cognitive loss in dementia. This will be 
tested by comparing R2 and AIC values from regression equation 4 with 
regression equation 3. For example, if the R2 value in equation 4 is 
moderate and the R2 value in equation 3 is strong, then the null hypothesis 
can be rejected. Alternately, if the AIC of model 3 is less than the AIC 
value of model 4 by 4 or more, then the null hypothesis can be rejected. 
H03:  Education correction decreases or has no effect on the extent to 
which NP tests are able to capture functional decline due to cognitive loss 
in dementia.  
Optimal demographic correction (as determined via the analyses above) will result in 
better diagnostic performance when differentiating normal controls from individuals with 
dementia. Comparison of the R2 values of the various regression equations presented 
above will clarify the extent to which various types of demographic correction (e.g., age, 
education, age & education) influence the ability of cognitive tests to detect meaningful 
variation in dementia severity. While the above tests are not associated with significance 
levels, R2 values and AIC values are used commonly to compare non-nested models and 
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allow the important research questions above to be answered quantitatively albeit not 
with a given significance level as in a traditional null hypothesis testing approach.  
Nature of the Study 
This was a quantitative study of concurrent case-referent design for evaluating 
test-criterion relationships. This study looked at the relationship between the cognitive 
tests, normed different ways, and the clinical dementia severity rating (CDR-SB) using 
hierarchical multiple linear regression. Prior to modeling, the data was described by 
calculating descriptive statistics including the mean, standard deviation, and a range of all 
study variables. The intercorrelations of the cognitive test scores, age, education, and the 
CDR-SB was calculated for each of the 4 different norming methods using bivariate 
Pearson correlations (one correlation matrix per norming method). The correlations 
provided a direct measure of the strength of the relationship between all quantitative 
study variables and aided in the interpretation of the hierarchical multiple linear 
regression analyses for testing the primary study hypothesis, help detect suppression, and 
served as a measure of variable importance (Nathans et al., 2012). Following descriptive 
statistics and analysis of intercorrelations between tests, the primary study hypotheses 
was tested using least squares hierarchical multiple linear regression. Each set of 
cognitive composites, one per norming method, was regressed on the CDR-SB. Because 
there are no universally accepted statistical tests by which to compare these non-nested 
models, these differences were evaluated quantitatively using R2 values and AIC values, 
but were not be associated with a significance level. This told us the extent to which these 
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different methods of scoring captured clinically meaningful variations in dementia 
severity status and the extent to which they differed from one another.  
Hierarchical multiple regression was chosen for this analysis because it allowed 
us to fit a model to the data that enabled the prediction of the outcome variable, the CDR-
SB, from a number of different independent variables, the cognitive tests for each of the 4 
cognitive domains scored 4 different ways. This technique is appropriate when examining 
the magnitude of association between a set of continuous predictor variables and a 
continuous outcome variable (Field, 2013). The comparison of the R2 and AIC values 
from the resulting models facilitated an exploration of the extent to which different 
scoring methods differed in their ability to capture meaningful variability in dementia 
severity status. Identifying optimal norming methods facilitates greater diagnostic 
accuracy in the context of dementia.  
Sources of Data 
The University of Washington’s NACC is funded by the National Institute on 
Aging and maintains a valuable resource, a cumulative database with which researchers 
can collaborate (NACC, 2010). The NACC shares all data, providing an excellent 
resource for investigating cognitive aging and dementia in a well-defined cohort. This 
data, the Universal Data Set (UDS), will be obtained from the NACC who took the first 
steps to standardize data collection across the ADCs in 1999 in an effort to advance better 
research hypotheses; by the end of 2016 data had been collected from 34,748 participants 
(Weintraub et al., 2018a). Participants with normal cognition, MCI, and various 
etiologies of dementia are recruited and followed annually. Data collection using Version 
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3 began in March 2015 as part of an ongoing effort to produce a uniform data set with an 
updated NP battery allowing research institutions to collaborate using freely available 
standardized instruments (Besser et al., 2018). The current study used the updated 3rd 
version of the NACC’s UDS Neuropsychological Assessment Battery (UDS-3 NAB) 
which included measures of dementia severity, verbal and nonverbal memory, executive 
function, language, and attention (Besser et al., 2018). The instruments produced both 
raw test scores and age- and education-corrected scores and were modeled as a function 
of the patient’s dementia severity level as measured by the CDR-SB. All identifying 
information of the subjects was scrubbed prior to the dissemination of the data to assure 
complete confidentiality.  
Summary 
 Since the first standardized psychological testing was used to quantify an 
individual’s performance and compare it across groups, norm-referenced scoring was 
used to make raw scores more relevant and useful. Researchers draw conclusions about 
an individual’s performance by comparing scores to national norms that allow them to 
find if the person’s performance is “typical” and determine whether their functioning is 
at, ahead, or behind the norm. The presence of appropriate national norms is necessary 
for these conclusions. A recent proposal questions the utility of age- and education-
corrected scores in late adulthood, postulating that these norms may be contaminated 
with undiagnosed individuals in preclinical or prodromal stages of neurodegenerative 




AD and other dementias are some of the costliest conditions in our society and 
predicted to reach crisis levels as our oldest population grows faster than any other 
demographic and threatens to place great financial strain on our health care system. 
Secondary prevention trials are handicapped by a lack of cognitive outcome markers and 
the ability to classify impairment using standard normative data. The current search for a 
set of predictors, including cognitive biomarkers, that distinguish individuals who are 
experiencing the effects of normal aging from those in the process of developing 
neurodegenerative diseases gives rise to the question concerning the utility of raw scores 
versus demographically-corrected scores in norm-referenced cognitive testing of an older 
population. The current study aimed to explore the strength of the relationship between 
tests scored different ways and dementia severity with the ultimate goal of finding which 
way of scoring was most diagnostically accurate.  
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Chapter 2: Literature Review 
The literature review in this chapter justifies the need for additional research to 
examine whether the current standard practice of age- and education-correcting scores in 
NP testing are best practice when attempting to differentiate between normal cognitive 
aging and dementia in an aging population. Some researchers championed the proposal 
that national norms are polluted with undiagnosed individuals in the early stages of 
dementia, decreasing the tests’ ability to detect cognitive impairment (Hessler et al., 
2014; Holtzer et al, 2008; O’Connell & Tuokko, 2010; Wyman-Chick et al., 2018). But 
others failed to support this hypothesis and current practice still adheres to demographic 
correction (Malek-Ahmadi et al., 2015; Quaranta et al., 2016). This study addressed a 
current debate in the literature over which set of data, normative or raw scores, best 
predict the patient’s clinical level of dementia using data obtained from NACC’s ADCs. 
The current study may further the utility of NP testing in the service of earlier and more 
accurate detection of neurodegenerative diseases because optimal demographic correction 
will result in better diagnostic performance when differentiating normal controls from 
individuals with dementia. 
This chapter starts by addressing the major social problem, the public health 
burden of dementia. It then covers an overview of dementia including the concept of 
MCI, and the criteria for dementia diagnosis. From there, dementia is discussed starting 
with the most common etiology, Alzheimer’s disease (AD), followed by how the testing 
profiles of the next common causes of dementia compare and contrast, including vascular 
dementia, Lewy body disease, frontotemporal dementia, and Parkinson’s disease. A 
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history of psychological and educational testing is explored and connected to the role of 
NP testing in a clinical setting with an emphasis on norm referenced interpretation in NP 
assessment, methods of norming, and norm referenced interpretation specifically for 
dementia diagnostic evaluations.  
The literature search included articles electronically accessed through Walden 
University library’s databases; Academic Search Complete; Google Scholar; Mental 
Measurements Yearbook with Tests in Print; Proquest; psycTESTS; PubMed; SAGE; 
Taylor and Francis Online; Thoreau; World Health Organization (WHO), and open 
access articles from PubMed.gov and NIH.gov. Other resources such as UpToDate and 
Elsevier were accessed through an alternative institution’s library databases. Search terms 
included; Alzheimer’s disease; dementia; dementia assessment; diagnostic accuracy and 
dementia assessment; diagnostic accuracy and memory impairment; diagnostic accuracy 
and mild cognitive impairment; NP assessment and dementia; demographic correction 
and neuropsychology and dementia; and demographic correction of NP test scores. 
Multiple books, both in print and electronically, were also accessed and reviewed for 
relevant information. The search had a rough scope over the last decade with an emphasis 
on the last 5 years of research, even though it was necessary to look into the annals of 
history when tracing the origins of psychological and educational testing theory.  
The Public Health Burden of Dementia 
Our healthcare system is about to face an unprecedented challenge as the growth 
of our oldest population, the baby boom generation, reaches the age of high risk for the 
development of neurodegenerative diseases like AD and other types of dementia (AA, 
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2018; Gill, 2015; Livingston et al., 2017; Smith & Bondi, 2013; WHO, 2018;). As the 
number of older Americans increases rapidly due to medical advances and better 
environmental conditions, so will the number of new cases of dementia. Significant 
financial, medical, and emotional benefits will result from earlier intervention because 
disease-modifying and psychosocial interventions are most effective early in the disease 
process; delaying the onset of the disease, even just for one year, has significant benefits 
due to the long duration of the illness prior to death that carries a heavy emotional and 
financial burden. (AA, 2018; Dubois et al., 2016; Hurd et al., 2013; Langa & Levine, 
2014; Rockwood et al., 2014; Smith & Bondi, 2013; Sperling et al., 2011; Ward et al., 
2013; Wei-Hong et al., 2017; Zissmopoulos et al., 2014).  
 Lifetime expenditures for an individual with dementia are roughly $341,840, three 
times more than the cost of care for people without dementia for the same age group 
(AA, 2018). Medicare and Medicaid cover 67% or $186 billion of the total $277 billion 
in these costs, deeming this issue a major social problem (AA, 2018). Payments in every 
category; primary care physicians; specialists; lab services; medication; emergency room 
visits; inpatient hospital stays; skilled nursing facilities; and hospice care are higher for 
those with dementia, 23 times greater than those who remain dementia free (AA, 2018). 
Even with the financial assistance from Medicare and private insurance, out-of-pocket 
expenses are an additional burden to an already emotionally stressed family dealing with 
the dementia diagnosis of a loved one.  
 In addition to medical expenses and lost economic value for unpaid care, 
dementia caregivers reported more physical and mental health issues than the general 
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population (AA, 2018; Ma et al., 2018; Roth et al., 2015; Solway, 2017). Caregivers 
spend an average of 21.9 unpaid hours a week caring for a loved one with dementia (AA, 
2018). This often exacerbates their own health issues; increases emotional stress and 
depression; and depletes income and finances due to disruption in employment and 
additional personal health care expenses (AA, 2018; Ma et al., 2018; Roth et al., 2015; 
Solway, 2017). This caregiver strain was even shown to increase the caregiver’s risk of 
death (Roth et al., 2015). While most caregivers reported caring for their loved one was 
rewarding, they also acknowledged the role is highly stressful (AA, 2018; Solway, 2017). 
This is such a prominent issue that the National Academies of Sciences, Engineering, and 
Medicine (2016) released a report entitled Families Caring for an Aging America which 
focused on national health care reform efforts that recognize the role of family members 
and encourage health care providers to deliver evidence-based services to both care 
recipients and their caregivers.  
Other benefits for the individual include early intervention programs such as 
cognitive rehabilitation that maximizes reserved cognitive resources by teaching 
compensatory strategies, behavioral interventions like diet and exercise that may increase 
quality of life and prolong independence, and estate and care planning while the person 
can still participate (AA, 2018; Livingston et al., 2017). Changing the trajectory of AD 
and other neurodegenerative diseases has the potential to improve the lives of patients, 
their families, and society as a whole.  
The WHO (2018) called to prioritize dementia as a global health issue and 
reported the prevalence and financial burdens of people living with syndromes of 
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cognitive impairment worldwide, proposing the need for public policies to address the 
impending crisis: 
Almost 9.9 million people develop dementia each year, the majority (63%) 
of whom reside in low- and middle- income countries. Dementia currently 
affects approximately 50 million people worldwide; a number that is 
projected to grow to 82 million by 2030 and 152 million by 2050. It is the 
second largest cause of disability for individuals aged 70 years and older, 
and the seventh leading cause of death. Dementia imposes an estimated 
economic cost of approximately US $818 billion per year globally – or 
1.1% of global gross domestic product. Left unaddressed, dementia could 
represent a significant barrier to social and economic development. (p. 6)  
Research focused on earlier and more accurate diagnoses is part of the formula leading to 
improvements in biomedical, psychological, and social interventions that have the 
potential to reduce the number of new cases by 10-20% because of their potential to ease 
the physical, psychosocial, and financial hardships for individuals, their families, and 
developing nations (AA, 2018; WHO, 2018).  
Overview of Dementia  
Normal or Abnormal Cognitive Aging?  
The life-span perspective classifies human development from conception to death, 
encompassing all stages and phases of growth, maturity, and aging. Viewing aging 
through this lens allows for a model that avoids pejorative or abnormal terms when 
psychological processes such as cognition change during the maturation process. It is 
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clear that adults peak cognitively between the ages of 20 and 40, but it is also established 
that fluid intelligence, efficient functioning of the central nervous system, declines 
steadily over adulthood beginning at age 35 or 40 (Boyd & Bee, 2019). Given ample 
time, older adults will still come up with the adequate answers, just not as quickly as 
younger adults. Using a life-span perspective, cognitive changes due to aging are not seen 
as an abnormal condition, but rather a normal developmental stage of life. The difference 
between normal cognitive aging and abnormal cognitive aging is an impairment that is 
distinct from normal aging, not typical of age-matched peers, and objectively measurable 
using NP testing measures. 
Cognitive changes are measured by NP testing, tests designed to detect 
quantitative or qualitative changes in the main cognitive domains of memory, executive 
function, language, attention, processing speed, and visuospatial skills. When an 
individual scores > 1 SD below the age corrected normative mean on a testing measure in 
a single domain with no interference in Instrumental Activities of Daily Living (IADLs; 
e.g., driving, managing one’s finances, self-managing medications, using the community, 
etc.) a diagnosis of MCI may be made. When the individual scores > 1 SD below the age 
corrected normative mean in multiple domains leading to difficulty with IADLs then a 
diagnosis of dementia may be considered. There is a general acknowledgment that 
preclinical dementia-related neuropathology is present in normally aging individuals 
prior to any measurable cognitive decline (Mortamais et al., 2017; Ritchie et al., 2015; 
Rockwood et al., 2014; Smith & Bondi, 2013; Sperling et al., 2011; Sutphen et al., 2015 
Ward et al., 2013; Wei-Hong et al., 2017). This grey area, the phase between normal 
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cognitive functioning and clinical dementia, is seen as the most promising period for 
disease-modifying interventions that have the potential to alter the trajectory of the 
disease and has come to be widely accepted as the concept of MCI.  
Our ability to predict which patients with MCI will remain stable, typical of 
normal aging, versus which will convert to dementia and continue to decline, is a major 
goal in current research. NP testing plays an important role in the multidisciplinary search 
for answers (Bondi et al., 2014; Smith & Bondi, 2013). NP testing becomes a key front-
line component in the detection of preclinical dementia because, unlike a lumber 
puncture, it is non-invasive, does not require expensive medical equipment like brain 
imaging, and is easy to administer in a variety of clinical settings.  
The Evolution of the Concept of MCI 
Kral’s (1962) seminal work delineated the difference between “benign” (normal) 
and “malignant” (pathological) aging, many terms have been proposed to describe the 
concept of the “not-normal but not-demented clinical state”, and MCI has clearly gained 
widest acceptance (Smith & Bondi, 2013, pp. 72-73). Petersen et al., (1995) adopted the 
term MCI as a diagnostic entity to reflect the earliest objectively measurable deficits in 
cognition when it is no longer normal relative to expectations for age, but the individuals 
can still live and function independently. The first guidelines for MCI proposed by 
Petersen et al. (1999) recommended that general criteria include a non-demented 
individual (does not meet the DSM criteria for a dementia syndrome) with generally 
intact cognition, preserved Activities of Daily Living (ADLs; e.g., personal hygiene, 
continence management, dressing, feeding, and ambulating) and minimal impairment of 
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IADLs, but experiencing subjective memory complaints that can be objectively 
measured. Smith and Bondi (2013) explained the concept of MCI and its meaning for the 
clinician: 
MCI constitutes that level of cognitive function wherein low-functioning 
normal older persons and high functioning dementia patients cannot be 
reliably distinguished. If all persons labeled as MCI are conceived of as 
belonging in either a normal population, not destined to develop dementia, 
or from a population that is developing dementia, then MCI can be thought 
of not as a condition present in the patient, but rather as a state of 
uncertainty in the clinician. (p. 73)  
MCI was incorporated into the DSM-5 as a mild neurocognitive disorder and is central in 
the field because it is considered a significant risk factor for the subsequent development 
of dementia. While a percentage of people with MCI remain stable, and a smaller 
percentage may recover completely, estimates varied from 43% to 83% conversion rate 
to dementia depending on the methodology used; but it is agreed that these patients are at 
higher risk for developing dementia (Bondi et al., 2014; Mazaheri et al, 2018; Mitchell & 
Shiri-Feshki, 2009; Petersen et al., 1999; Petersen et al., 2013; Petersen et al., 2015; 
Smith & Bondi, 2013; Ward et al. 2013; Wimblad et al., 2004). MCI is also important 
because it is the window when the least damage has occurred making it an ideal target for 
interventions. Thus, the concept defined as MCI has become a primary focus for research 
in neurodegenerative diseases.  
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Early in the MCI research, total learning score, also referred to as immediate 
recall, emerged as the single most sensitive and specific measure for distinguishing MCI 
from normal aging; researchers found the addition of a delayed recall measure enhanced 
classification accuracy and improved prediction of progression to AD dementia (Bondi et 
al., 2014; Smith & Bondi, 2013). As the conception of MCI evolved, it became 
recognized as a pathologically heterogeneous disorder and the concept was broadened to 
include deficits in other domains besides just memory (Smith & Bondi, 2013; Wimblad et 
al., 2004).  
A multidisciplinary consensus conference in 2003 expanded MCI into three 
subtypes, amnestic, multiple domain, and single nonmemory domain (e.g., language or 
visuospatial) and listed multiple possible etiologies; degenerative; vascular; metabolic; 
traumatic; psychiatric; and “others” (Wimblad et al., 2004). This was an important 
revision in the concept as subcortical dementias like Parkinson’s and Huntington’s 
diseases may leave memory relatively intact in the early stages while the first measurable 
deficits appear as compromised attention and processing speed (Smith & Bondi, 2013; 
Wimblad et al, 2004). Comprehensive NP testing is the best way to classify the specific 
subtype of MCI (Bondi et al., 2014; Wimblad et al., 2004).  
In 2013, the DSM-5 (APA, 2013) classified MCI as Mild Neurocognitive 
Disorder and established the following criteria for diagnosis: 
A. Evidence of modest cognitive decline from a previous level of 
performance in one or more cognitive domains (complex attention, 
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executive function, learning and memory, language, perceptual-
motor, or social cognition) based on: 
1. Concern of the individual, a knowledgeable informant, or 
the clinician that there has been a mild decline in cognitive 
function: and 
2. A modest impairment in cognitive performance, preferably 
documented by standardized neuropsychological testing or, 
in its absence, another quantified clinical assessment.  
B. The cognitive deficits do not interfere with capacity for 
independence in everyday activities (i.e., complex instrumental 
activities of daily living such as paying bills or managing 
medications are preserved, but greater effort, compensatory 
strategies, or accommodation may be required).  
C. The cognitive deficits do not occur exclusively in the context of a 
delirium. 
D. The cognitive deficits are not better explained by another mental 
disorder (e.g., major depressive disorder, schizophrenia). (p. 605) 
When testing outcome shows that an individual’s memory is significantly lower 
than age expectations, but other domains (attention, language, visuospatial skills, and 
executive functions) remain intact, amnestic MCI is the preferred classification. If mild 
deficits are found in a number of different domains, multidomain MCI (with or without a 
memory component) is more appropriate. When one nonmemory domain is impaired, 
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such as visuospatial skills, then single nonmemory domain MCI is the most applicable.  
After a diagnosis of MCI is made and classified, then the clinician must attempt to 
determine the etiology of the impairment and plan for monitoring or treatment. The 
differential diagnosis of a cognitive disorder requires an extensive workup given the 
serious consequences of progressive degeneration and impending disability. NP testing 
plays an important role in the push for earlier and more accurate diagnoses that will allow 
for disease-modifying treatments to be developed, tested, and utilized successfully (Bondi 
et al., 2014; Mortamais et al., 2017; Smith & Bondi, 2013).  
The difference between MCI and dementia is the severity and prognosis. Once the 
criteria are met for a dementia diagnosis, there is progression over time. MCI, on the 
other hand, while considered a significant risk for future dementia does not always 
progress. Current research estimates the majority of patients with MCI transition to 
dementia within 5 years of the MCI diagnosis (Mazaheri et al., 2018). Differential 
diagnosis demands a comprehensive clinical assessment that includes a full neurological 
exam, brain imaging studies, and NP testing (Bondi et al., 2014; Mazaheri et al., 2018; 
Mortamais et al., 2017; Petersen et al., 2014; Smith & Bondi, 2013). The early and 
accurate diagnosis of MCI is increasingly important as patients are presenting concerns to 
their primary care physicians earlier, and secondary prevention trials seek to intervene 
sooner in the disease process to limit permanent damage to the brain. 
Dementia Criteria 
The term dementia is customary in most settings, but the DSM-V reclassified 
dementia as major neurocognitive disorder (APA, 2013). Some of the earliest research on 
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aging defined two types of changes related to cognition and behavior, “benign” and 
“malignant” (Kral, 1962). Benign changes were typical, developmental changes 
associated with aging and unrelated to diseased brain tissue, in other words, normal 
aging. Malignant changes were histopathological brain changes that were progressive in 
nature. As research continued, the focus became the ability to distinguish a normally 
aging individual, who was worried about their memory function enough to complain to 
their primary care provider, from a malignant or neurodegenerative process (Smith & 
Bondi, 2013). Currently, the DSM-V sets the consensus diagnostic criteria for a major 
neurocognitive disorder as:  
A. Evidence of significant cognitive decline from a previous level of 
performance in one or more cognitive domains (complex attention, 
executive function, learning and memory, language, perceptual-
motor, or social cognition) based on: 
1. Concern of the individual, a knowledgeable informant, or the 
clinician that there has been a significant decline in cognitive 
function; and  
2. A substantial impairment in cognitive impairment in cognitive 
performance, preferably documented by standardized 
neuropsychological testing or, in its absence, another quantified 
clinical assessment.  
B. The cognitive deficits interfere with independence in everyday 
activities (i.e., at a minimum, requiring assistance with complex 
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instrumental activities of daily living such as paying bills or 
managing medications). 
C. The cognitive deficits do not occur exclusively in the context of a 
delirium.  
D. The cognitive deficits are not better explained by another mental 
disorder. (APA, 2013, pp. 602-603) 
 The DSM-V requires the clinician to specify the etiology of the major 
neurocognitive disorder, a discussion of all the causes is beyond the scope of this paper, but 
the most prevalent causes are addressed in the following subsections. The most common 
cause of dementia is AD. The second most common cause is vascular disease, followed by 
Lewy body disease, and frontotemporal lobar degeneration (Ramirez-Gomez et al., 2017; 
Smith & Bondi, 2013). While AD, Lewy body disease, and frontotemporal dementia are all 
classified as neurodegenerative diseases, vascular disease is more diverse and does not 
always conform to the same standards. NP profiles and patterns aid in distinguishing these 
underlying pathologies (Ramirez-Gomez et al., 2017; Smith & Bondi, 2013; Stephan et al., 
2017). This is why the number of people that can be helped using a NP perspective is 
increasing.  
Alzheimer’s Disease 
 Over a century ago Alois Alzheimer, considered the father of neuropathology, 
was the first to describe a patient with the progressive form of dementia that now bears 
his name (Möller & Graeber, 1998). AD is the most common cause of dementia 
accounting for up to 80% of all cases (AA, 2018; Sutphen et al., 2015). In the United 
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States, one person develops the disease every 65 seconds (AA, 2018). Current estimates 
support that 10% of people age 65 have AD, with the prevalence of the disease increasing 
exponentially with age: three percent of people age 65-74, 17% of people age 75-84, and 
over 40% of people age 85 and older (AA, 2018; Hebert et al., 2013).  
 The first individuals to be born into the baby boom generation turned 72 in 2018, 
placing them at high risk for neurodegenerative disorders (AA, 2018). The rapid increase 
of our oldest population over the coming decades will stress our health care system as 
demand for medical care and long-term services will increase, placing a huge burden on 
Medicare that will cause a major economic ripple on our Nation’s budget (Barnett, et al., 
2014; Dubois et al., 2016; Hurd et al., 2013; Rockwood et al., 2014; Zissmopoulos et al., 
2014). Estimates claim a $935 billion in savings that can be realized over the 10-year 
period from 2026-2035 with an overall $7.9 trillion savings for the current U. S. 
population (AA, 2015). Our Nation will benefit from earlier and more accurate detection 
of neurodegenerative diseases like Alzheimer’s because of the potential to improve the 
lives of the millions of individuals yet to be diagnosed.  
 Prior to updated guidelines in 2011, a formal diagnosis of AD required that an 
individual already exhibit significant problems with learning, thinking, or memory. The 
seminal work of Braak and Braak (1991) changed how AD was viewed based on the 
discovery of neurofibrillary tangles (a known biomarker of AD) in people as young as 30. 
This sparked a surge of research that led to Jack et al.’s (2010) continuum model of AD 
that begins with a preclinical period, decades before symptoms appear but when 
biological changes are already taking place in the central nervous system, moving into 
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MCI where cognitive decline can be objectively measured, and finally full-blown 
Alzheimer’s dementia. This revised model of the Alzheimer’s trajectory continues to 
guide most of the current direction in research and practice with the hopes that disease-
modifying interventions will be developed and utilized during the earliest stages to 
change the course of the disease prior to total dementia setting in (Jack et al., 2013).  
 It is certain that a preclinical stage of AD begins decades before symptoms 
appear, when biological changes take place, but the individual remains asymptomatic 
(AA, 2018; Jack et al., 2013; Jack et al., 2015; Mazaheri, 2018; Mortamais et al., 2017; 
Ritchie et al., 2015; Sutphen et al., 2015). This has led some researchers to categorize AD 
as a disease of midlife rather than of old age (Ritchie et al., 2015; Sutphen et al., 2015). 
Jack et al. (2013) proposed the main AD biomarkers change in a temporally ordered 
manner; starting with an abnormal accumulation of amyloid β protein (Αβ) as plaques, 
and hyper phosphorylated tau protein as neurofibrillary tangles that can be assessed by 
measures of cerebral spinal fluid (CSF) Aβ and tau. This is followed by the biomarkers of 
neurodegeneration indicated by brain imaging, hypo metabolism on fluorodeoxyglucose 
(FDG) PET, and structural MRI, that finally lead into the clinical symptoms and 
measurable cognitive decline (cognitive biomarkers). This insidious onset is included in 
the diagnostic criteria for AD. The current model assumes “the maximum rate of change 
moves sequentially from one biomarker class to the next, and as the disease progresses all 
biomarkers become progressively more abnormal simultaneously…at rates that change 
over time in an ordered manner” (Jack et al., 2013, p. 207). The rate of progressive 
cognitive impairment is “loosely coupled” with the amount CSF Aβ, but “closely 
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coupled” with imaging neurodegenerative biomarkers (Jack et al., 2013). It was also 
noted that the time needed to travel the course of the disease varies among individuals 
because it is mediated by baseline differences in brain plasticity and cognitive reserve, as 
well as the presence of other pathophysiology like cerebrovascular disease or Lewy 
bodies, which often co-occur with AD and contribute to an individual’s variation and 
presentation (Jack et al., 2013; Karantozoulis & Galvin, 2011; Smith & Bondi, 2013).   
 In the Alzheimer’s continuum, MCI is thought of as the period that reveals the 
first objectively measurable cognitive deficits due to neuropathological brain changes that 
occur in the course of the disease, and also where therapeutic trials designed to prevent 
cognitive decline are most useful (AA, 2018; Livingston et al., 2017; Mortamais et al., 
2017; Sutphen et al., 2015). Once brain changes are so significant that cognition and 
physical functioning decline, risk reduction and medical interventions are of little value 
(AA, 2018; Peall & Robertson, 2015). The problem remains in the obvious detail that by 
definition of being asymptomatic, the preclinical phase avoids detection using current 
cognitive measures. Empirically validated innovations for detection using a NP testing 
perspective are critically needed.  
 Our ability to diagnose individuals earlier and more accurately for the purpose of 
testing and utilizing disease-modifying treatments are the key to changing the trajectory 
of neurodegenerative diseases. Mortamais et al. (2017) asserted: 
 The design of secondary prevention trials targeting the preclinical period 
has thus been handicapped up to this point by that lack of proximal 
cognitive outcome markers. The cognitive tests currently used to describe 
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AD, having been largely derived from comparisons of persons with and 
without dementia, are by definition inappropriate for preclinical studies. 
Such early cognitive changes, if they exist, are likely to be subtle, requiring 
highly sensitive tests that target specific brain regions affected early in the 
disease process. (p. 469)  
AD is a prototypical cortical dementia with the most salient cognitive biomarkers 
markers being episodic memory impairments (learning and retention measures), that 
when coupled with the presence of a molecular biomarkers, like CSF Aβ and tau or FDG 
PET, clinicians can be fairly certain the individual will progress into AD dementia 
(Mortamais et al., 2017; Smith & Bondi, 2013). Episodic memory impairment is the most 
prominent predictor of dementia, but aphasia and apraxia are also common features and 
can be measured by lower performance in verbal fluency, processing speed, and fluid 
reasoning (Karantzoulis & Galvin, 2011; Mortamais et al., 2017; Smith & Bondi, 2013). 
During recognition memory testing, patients with AD do not benefit from cueing and 
tend to show greater false-positive errors (Karantzoulis & Galvin, 2011). As the disease 
progresses, language skills continue to deteriorate, and global aphasia and muteness are 
common. Traditionally, cognitive dysfunction was viewed as the outcome of AD and 
other dementias. Mortamais et al. (2017) argued that increasing evidence supports that 
cognitive changes can be detected in preclinical stages of dementia rather than waiting 
for a clinical diagnosis and there is a need for “comprehensive evidence-based guidelines 




 Vascular dementia (VaD) is an umbrella term that refers to any dementia caused 
by impaired cerebral blood flow due to cerebrovascular disease or brain injury. It was 
included in the DSM-5 as a major cognitive disorder. VaD is the second most common 
form of dementia but it is not classified as a neurodegenerative disease, only AD leads in 
incidence. Pure VaD is relatively uncommon, but it is a contributor in an estimated half 
of clinical- and population-based studies, most often in combination with AD and 
diagnosed as mixed dementia ([MD]; Blom et al., 2014; Kang et al., 2016; Smith, 2017; 
Smith & Bondi, 2013). While rare in its pure form, it can cause dementia (Ramirez-
Gomez et al., 2017; Smith, 2017; Smith & Bondi, 2013; Stephan et al., 2017). VaD 
generally has a more abrupt onset than AD (Karantzoulis & Galvin, 2011; Smith & 
Bondi, 2013). Typically, it is identified in one of two ways, either a stroke is diagnosed 
which is then followed by the onset of dementia, or a patient with no history of stroke 
complains of cognitive decline and neuroimaging or neuropathology reveals the vascular 
brain injury (Smith, 2017). Cognitive impairments due to vascular issues are also 
diagnosed on a spectrum, with the severity of the vascular disease correlated with the 
extent of the cognitive impairment ranging from MCI with a vascular etiology, also 
known as vascular cognitive impairment to all-out VaD when the criteria for dementia is 
met (Ramirez-Gomez et al., 2017; Stephan et al., 2017). Just like with AD the prevalence 
of vascular dementia increases after 65 years of age and factors related to the brains 
ability to compensate for the level of pathology makes it difficult to use neuroimaging 
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alone to diagnose the severity of VaD. NP testing becomes an important factor in the 
comprehensive clinical assessment used make the final diagnosis.  
 In addition to age, there are other risk factors associated with vascular dementia; 
hypertension; diabetes; high cholesterol; sedentary lifestyle; low or high body mass 
index; smoking; coronary artery disease; and atrial fibrillation (Livingston et al., 2017; 
Smith & Bondi, 2013). Cerebral blood flow becomes impaired through slow cumulative 
processes that lead into cerebral small vessel disease or may have a sudden onset from a 
single major event such as a hemorrhagic stroke (Blom et al., 2014; Ramirez-Gomez et 
al., 2017; Smith, 2017; Smith & Bondi, 2013; Stephan et al., 2017). Cortical signs of 
stroke may include aphasia and apraxia, but the NP profile of an individual post stroke 
varies because it is directly related to the stroke location and severity (Smith & Bondi, 
2013; Stephan et al., 2017). The mere presence of a cerebrovascular brain injury does not 
necessarily signal dementia or indicate impending dementia.  
 There are many different cardiovascular and cerebrovascular incidents that lead to 
cognitive dysfunction and different vascular disorders have different patterns of cognitive 
impairment (Kang et al., 2016; Ramirez-Gomez et al., 2017; Stephan et al., 2017). People 
with vascular dementia tend to experience motor issues more often than those with AD, 
such as a slowing of gait, and neuropsychiatric signs like depression, apathy, psychosis, 
or sudden and inappropriate laughing or crying known as pseudobulbar affect (Smith & 
Bondi, 2013). When vascular dementia is suspected, the cognitive profile is examined 
along with a complete health history, risk factors, brain imaging, and the presence or 
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absence of biomarkers of other neurodegenerative diseases that may be contribute to 
cognitive decline such as the presence of CSF Αβ (Smith & Bondi, 2013).  
 The NP profile for VaD is typically characterized by poor executive function that 
includes decreased inhibition and processing speed; poor planning and problem solving; 
and difficulties with task changing, working memory, and attention, but the variety of 
incidents that lead to vascular cognitive dysfunction makes it difficult to typify a pattern 
across all vascular conditions (Karantzoulis & Galvin, 2011; Ramirez-Gomez et al., 
2017; Smith & Bondi, 2013; Stephan et al., 2017). While episodic memory impairment is 
a hallmark of the AD diagnosis, those with VaD typically respond better to recognition 
and cueing of learned information (Karantzoulis & Galvin, 2011; Ramirez-Gomez et al., 
2017). Measures of verbal fluency showed greater impairment of phonemic (letter) 
fluency in VaD versus greater impairment of semantic (category) fluency in AD 
(Ramirez-Gomez et al., 2017). Ramirez-Gomez et al. (2017) found phonemic and 
semantic differences alone did not distinguish AD from VaD, but when they generated a 
formula that incorporated the first learning trial of a word memory test, they were able to 
classify AD from VaD in an autopsy confirmed cohort with moderate sensitivity and 
specificity, but asserted additional independent studies were necessary to confirm their 
hypothesis.  
 Vascular dementia may mimic AD depending on the location of the infarct, and 
the fact that it is often found in combination with AD as MD makes it even more difficult 
when testing profiles have significant overlap (Karantzoulis & Galvin; 2011; Kang et al., 
2016). When comparing a pure AD etiology to MD, the frontal lobe deficit patterns of 
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VaD overlap with the medial and lateral temporal lobe deficit patterns of AD. Kang et al. 
(2016) found significant differences in the milder stage of dementia where the NP 
profiles of MD demonstrated lower performance on executive function and semantic 
fluency but maintained a memory advantage over AD into a moderate stage of dementia. 
As the severity of the dementia increased, testing patterns and profiles were harder to 
distinguish from one another as no significant differences were found in attention, 
language, visuospatial, or memory scores (Kang et al., 2016). Another conclusion from 
Kang et al.’s study was that AD patients appeared to maintain better ADLs making the 
rating of functional performance an important piece of the differential diagnostic puzzle. 
The current study includes a clinical dementia staging instrument, CDR, considered a 
gold standard for capturing daily functional performance  
related to dementia. Clearly the variations in cognitive profiles across VaD make it 
challenging to come to a consensus on which cognitive tests best capture the information 
needed to support an MCI due to vascular conditions or a VaD diagnosis (Stephan et al., 
2017). Comprehensive testing across all domains allows clinicians to identify cognitive 
strengths and weaknesses to rule out alternative explanations for the impairments, and the 
use of the CDR as a measure of functional performance helps support the final diagnosis.  
Lewy Body Disease 
 Dementia with Lewy bodies (DBL) is considered one of the three most common 
forms of dementia and is the second leading neurodegenerative cause (McKeith et al., 
2017; Smith & Bondi, 2013). It has distinct clinical features including cognitive 
fluctuations; hallucinations; rapid eye movement (REM) sleep behavior disorder (RBD); 
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and parkinsonism; which typically appear early and persist throughout the course of the 
disease (McKeith et al., 2017). Unlike AD and VaD, the incidence of DLB does not 
appear to increase with age (Smith & Bondi, 2013). The First International Workshop of 
the Consortium on DLB convened in 1996 and established the classification of dementia 
with Lewy bodies (Rizzo et al., 2012). The pathologic hallmark of DLB is the Lewy 
body, an intracytoplasmic inclusion in deep cortical layers in the brain, especially the 
frontal and temporal lobes (McKeith et al., 2017; Rizzo et al., 2017; Smith & Bondi; 
2013). While short-term memory is typically the earliest deficit of an AD patient, 
impaired visuospatial function, attention, and executive function appear to be the most 
prominent deficits in early DLB (McKeith et al., 2017; Rizzo et al., 2017; Smith & 
Bondi, 2013). In fact, an absence of visuospatial impairment helps clinicians exclude 
DLB. Attention deficits vary from seconds to days and are interspersed with periods of 
near normal function; they may take the form of a brief cognitive fluctuation that 
interrupts the flow of an ADL or be severe enough for the individual to appear catatonic 
for a length of time (Smith & Bondi, 2013; McKeith et al., 2017). The CDR helps capture 
these fluctuations in consciousness.  
 Visual hallucinations are rare in AD but occur in up to 80% of individuals with 
DLB (McKeith et al., 2017). They are an early sign of DLB and are often under reported 
because the patient has a lack insight regarding the nature of the hallucinations. They 
may come in the form of people, animals, or inanimate objects that move or shape shift; 
or even more complex visual interactions like ongoing conversations with the dearly 
departed. Auditory hallucinations, hearing music, a TV, or voices nearby; olfactory 
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hallucinations, both pleasant and foul; and tactile hallucinations like feathers or fur 
brushing up against an arm or leg, or even insects crawling on their skin are also present 
in patients with DLB (McKeith et al., 2017). Another early sign that occurs in 85% of 
individuals and may precede clinical diagnosis by up to 20 years is RBD, characterized 
by recurrent dream enactment and vocalizations (Donaghy et al., 2018; McKeith et al., 
2017; Smith & Bondi, 2013). It can be mild or severe, and injuries can happen from 
striking a bed partner or suddenly jumping out of bed. RBD is not exclusive to DLB and 
can also occur in patients with Parkinson disease dementia. Gait disorders, limb rigidity, 
or a combination of the two, termed parkinsonism, is also present in 70%-90% of patients 
with DLB but usually in a milder degree than someone with Parkinson’s disease.  
 These types of overlapping clinical features make differential diagnosis 
challenging which is why NP testing plays an important role in a comprehensive clinical 
assessment to avoid serious negative side effects of certain treatment protocols. DLB 
continues to be under-recognized, and misdiagnosed as AD or Parkinson’s disease, so 
there is a need to refine diagnostic criteria to improve sensitivity and specificity as 
treatment efficacy is highly specific to DLB (McKeith et al., 2017; Rizzo et al., 2017). 
There are serious consequences when DLB is treated with the wrong types of 
medications; 30% to 50% of patients with DLB have severe antipsychotic sensitivity with 
reactions that may include irreversible parkinsonism, impaired consciousness, and even 
death (McKeith et al., 2017; Smith & Bondi, 2013; Rizzo, et al, 2017). These reactions 
are less common in Parkinson’s disease and have not been observed in AD. Donaghy et 
al. (2018) concluded the addition of neuropsychiatric symptoms other than hallucinations 
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(e.g., delusions, anxiety, depression, and apathy) to the core diagnostic features supported 
the differential diagnosis between DLB and AD.  
 The NP profile of DLB is a mixture of cortical and subcortical symptoms 
characterized by disproportional impairment in visuospatial, attention, and executive 
functions early on (Karantzoulis & Galvin, 2011; McKeith et al., 2017; Smith & Bondi, 
2013). When memory is impaired, usually later in the disease, encoding is typically less 
affected than retrieval; object naming is also typically preserved (Karantzoulis & Galvin, 
2011; McKeith et al., 2017; Smith & Bondi, 2013). No specific testing battery has been 
developed (Donaghy et al., 2018; McKeith et al., 2017), but comprehensive measures that 
includes spatial and perceptual tasks like complex figure copy and line orientation, and 
executive and processing speed measures like trail making tests and coding, are 
especially helpful in the differential diagnosis process when used in tandem with word 
memory lists, and object naming tasks.   
Frontotemporal Dementia 
 Frontotemporal dementia (FTD) has become an umbrella term for a group of 
clinically heterogeneous degenerative disorders affecting the frontal lobe alone, an 
isolated temporal lobe, or a degeneration of both the frontal lobes and temporal lobes. 
The most common subtypes are the behavioral variant (bvFTD) and two forms of 
Primary Progressive Aphasia (PPA), nonfluent and semantic variants (Lee, 2019; 
Ravskoski et al., 2011; Smith & Bondi, 2013). The main symptoms of bvFTD are 
persistent and significant changes in behavior and personality, while the main changes in 
PPA are a progressive deterioration of language skills. Because the pathology of each 
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variant is different, a consensus on the neuropsychology of FTD remains elusive. When 
contrasted with AD, memory is spared in the early course of the disease with better recall 
and recognition across all FTD syndromes (Smith & Bondi, 2013). Wittenberg et al., 
(2008) asserted that the difficulties to finding a consensus stems from still evolving 
diagnostic criteria, inconsistent findings in research, and the rare prevalence of FTD. 
Smith and Bondi (2013) claimed that FTD accounted for only about 5% of all dementias 
in an unselected autopsy series.  
 The most common subtype bvFTD accounts for nearly 50% of all FTD cases with 
an onset most common in the 6th decade of life but uncovered as early as the 2nd decade 
and as late as the 9th decade of life with only a 0.02% incidence rate in the general 
population (Lee, 2019). The primary characteristics are the pervasive behavioral changes 
that are often ignored or misdiagnosed for several years causing significant impact on the 
caregiver stress levels before a formal clinical diagnosis (Lee, 2019; Smith & Bondi, 
2013). Rascovsky et al. (2011) included the following symptoms in their outline for 
diagnostic criteria:  
A. Disinhibition – inappropriate and embarrassing public behavior 
B. Apathy, inertia, loss of sympathy, empathy, or changes in humor – 
indifference to others’ needs and feelings, less warmth and affection  
C. Hyperorality – changes in food preferences or decline in table manners  
D. Compulsive behaviors – obsessions with new hobbies or interests; smoking, 
alcohol use; or new religious and spiritual pursuits  
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E. A neuropsychological profile that shows a relative sparing of memory and 
visuospatial functions with deficits in executive functions  
 It is challenging to interpret NP test results in many patients with bvFTD due to 
substantial overlapping profiles with other neurodegenerative diseases. First, other 
medical illnesses (infarction, tumors, abscess, or trauma), substance abuse, psychiatric 
disorders, and other dementias such as AD or LBD must be ruled out (Lee, 2019; Smith 
& Bondi, 2013). Because individuals with bvFTD rarely have insight into their 
behavioral changes, a proper diagnosis is heavily dependent on the testimony of a 
knowledgeable informant. This is obtained via informant interviews during the clinical 
interview and through the CDR, a structured interview and informant testimony. Clearly, 
the significant personality and behavioral changes in bvFTD dwarf any behavioral 
disturbances present in AD, but in the temporal variants that are discussed below 
language and semantic knowledge are the most pronounced deficits. 
 The other syndrome of FTD is PPA characterized by an insidious onset of 
progressive language impairment that is evident in the early stages of the disease; 
prevalent deficits in word finding, word comprehension and usage, and sentence 
construction are present while other cognitive domains and ADLs are relatively spared 
(Gorno-Tempini et al., 2011; Mesulam, 2013; Smith & Bondi, 2013). Two variants of 
PPA have been delineated based on the type of language impairment; nonfluent or 
agrammatic, and semantic (Gorno-Tempini et al., 2011; Smith & Bondi, 2013). Word 
finding is the common feature across both subtypes of PPA, but the nonfluent variant has 
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more pronounced articulation problems while the semantic variant has more pronounced 
comprehension difficulties.  
 The main characteristic of nonfluent PPA is apraxia of speech as demonstrated by 
effortful, halting speech with speech-sound errors or distortions and agrammatism in 
language production; comprehension is spared for single words and simple sentences, but 
complex syntax poses problems (Smith & Bondi, 2013; Gorno-Tempini et al., 2011).  
The semantic variant PPA is marked by preserved fluent output, but simple 
comprehension becomes impaired through a loss of single word or object meaning and as 
the disease progresses comprehension becomes more globally impaired, episodic memory 
may decline, and behavioral symptoms such as rigidity of personality and loss of 
empathy may emerge (Mesulam, 2013; Smith & Bondi, 2013). A differential diagnosis is 
made by first ruling out other medical issues like cerebrovascular disease or tumors, then 
testing is used to discern the pattern of language deficits; the patient must also initially 
present with no impairments of episodic or visual memory, no visuospatial impairment, 
and no prominent behavioral disturbances (Lee, 2019). There is inconclusive evidence for 
the utility of NP testing in the diagnosis of FTD as the pattern of executive dysfunctions 
has not been distinguished from AD (Smith & Bondi, 2013). The challenges remain to 
improve the utility of NP testing and to clear the confusion behind the diagnostic criteria 
of FTD.  
Parkinson’s Disease 
 Parkinson’s disease (PD), once considered a disorder of only the motor system, is 
now widely recognized as a clinically diverse disease with three major subtypes; two of 
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which have more neuropsychiatric and nonmotor manifestations in addition to motor 
symptoms (Chou, 2019). The traditional tremor-dominant subtype has slower progression 
and less cognitive impairment than the akinetic-rigid subtype and the postural instability 
and gait difficulty subtype (Chou, 2019). The common clinical motor manifestations 
include tremor, bradykinesia, rigidity, and postural instability, while 97% of patients also 
present with nonmotor symptoms, some which manifest before motor symptom onset: 
• Cognitive dysfunction and dementia 
• Psychosis and hallucinations 
• Mood disorders – depression, anxiety, and apathy 
• Sleep disturbance 
• Fatigue 
• Autonomic dysfunction 
• Olfactory dysfunction 
• Gastrointestinal dysfunction 
• Pain and sensory disturbances 
• Dermatologic findings - seborrhea 
• Rhinorrhea 
PD and DLB share many overlapping clinical symptoms and pathological similarities 
such as parkinsonian features, psychosis, visual hallucinations, and fluctuating cognition 
making the differential diagnosis even more challenging (Chou, 2019). Clinicians and 
researchers use the convention of the “one-year rule”; if motor symptoms begin more 
than a year prior to the onset of dementia, then PD is diagnosed. When motor symptoms 
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present concurrently, or they start during the same year, then the diagnosis of DLB is 
given.  
 Cognitive dysfunction and dementia are common in PD with an estimated 78% 
incidence rate of dementia uncovered in longitudinal studies (Chou, 2019; Rodnitzky, 
2018). Subcortical dementias like PD typically spare memory in the early stages with the 
first NP manifestations appearing as psychomotor retardation, compromised executive 
function, and impaired attention and processing speed (Chou, 2019; Smith & Bondi, 
2013). As the disease progresses memory recall and visuospatial skills are more notably 
impaired with full dementia typically setting in later during the course of the disease. 
Cognitive testing plays a large role in determining the etiology of AD and all other types 
of dementia.  
The History of Educational and Psychological Testing 
Anastasi and Urbina (1997) wrote the classic comprehensive text on 
psychological testing that is still widely used in graduate programs. The authors wrote, 
“The roots of testing are lost in antiquity” (p. 32) but sketched an outline of the ground-
breaking pioneers that laid the foundation for educational and psychological testing as a 
valid and reliable method for collecting meaningful data about individuals. English 
biologist Francis Galton launched the modern testing movement when he established the 
need to measure characteristics of related and unrelated persons in the effort to further his 
research interests in heredity, leading to the first large systematic collection of data from 
his anthropometric laboratory (Anastasi & Urbina, 1997). In addition to developing 
rating-scales and self-report questionnaires, Galton also advanced the statistical methods 
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necessary for data analysis. Around the same time American psychologist James McKeen 
Cattell has just finished his dissertation on reaction time under the tutelage of Wilhelm 
Wundt in the first experimental psychology laboratory in Leipzig, Germany. Cattell’s 
chance encounter with Galton in 1888 while lecturing at Cambridge University, inspired 
Cattell to merge Wundt’s newly established science of experimental psychology with 
Galton’s even newer testing movement. The result of this early work was an upsurge of 
interest in testing and measures designed to quantify and classify human behavior and 
cognition.  
Frenchman Alfred Binet built on that foundation and constructed the first 
comprehensive test of intelligence in 1905 at the request of the Minister of Public 
Instruction in an effort to create proper procedures to educate children with mental 
retardation (Anastasi & Urbina, 1997). The 1905 scale, as it was known, originally 
consisted of 30 problems that required comprehension, reasoning, and judgment and was 
arranged from least to most difficult. The scale was administered to 50 “normal” children 
aged 3 to 11, and other children and adults with mental retardation. This preliminary 
scale had no objective method for arriving at a total score, but it caught the attention of 
psychologists around the world and was translated and adapted in many countries, 
including the United States. In the revised version, the 1908 scale, the researchers 
dropped the unsatisfactory tests and added others that had more promise. Simon and 
Binet then collected data on 300 normal children and grouped the results by age level. 
Any tests passed by 80 to 90% of normal 3-year-olds were grouped into a 3-year level; all 
tests passed by 4-year-olds were grouped into a 4-year level; and the same was done with 
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each age group up to 13. Thus, the foundation for a normative scoring system as a 
uniform frame of interpretation and reference was based on research with children, but 
Binet’s ill-timed death in 1911 left much work to be done.  
L. M. Terman and associates from Stanford University adopted Binet’s work in 
1916 and used it to build the broader and more psychometrically sound Stanford-Binet 
coining the use of a ratio between mental age and chronological age as an intelligence 
quotient (IQ). The work of these early psychometricians quickly diffused throughout the 
world and standardized psychological and educational testing forged ahead as an 
explosion of new measures and methods for analyzing data quickly followed. The 
Journal of Applied Psychology (JAP) chronicles the history that led to our understanding 
of measurement error and validation, as well as many other methodological areas of 
psychological testing (Cortina et al., 2017). From 1917 to 1925 the journal published the 
early work on the development and norming of cognitive ability testing for different 
populations and the beginning of statistical significance and prediction models with 
emphasis on psychometric properties and classification. Over the next 40 years, work on 
test scoring methods and cross validation dominated the publication while the following 
43 years witnessed an explosion of new measures and the data-analysis innovations that 
came along with them (Cortina et al., 2017). The current study builds upon the work of 
these early psychometricians and examines subgroup differences to validate optimal 
norms for an aging population.  
The use of testing in the field of neuropsychology began around WWII when the 
evaluation and recovery of brain injured soldiers created a new need in the field of testing 
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beyond sensory, vocational, and intelligence testing. Ralph Reitan, a recent college 
graduate, was given the task of assessing these brain-injured soldiers and found a lack of 
publications available for reference (Grant & Heaton, 2015). With the help of the 
hospital’s chief neurologist, John Anita, they published a series of four articles on the 
psychological consequences of brain injury. Anita encouraged Reitan to consult with 
psychologist Ward Halstead who he had seen lecture on the effects of brain injury. 
Through his new relationship with Halstead, he met Louis Thurston a mathematical 
psychologist from the University of Chicago Medical School and together the men 
encouraged Reitan to enter a graduate program in psychology (Grant & Heaton, 2015). 
“Through a combination of mishaps and serendipity”, Reitan ended up splitting his 
studies between medical school and psychology; and as a graduate student Reitan tested 
patients in Halstead’s laboratory using the instruments Halstead developed (Grant & 
Heaton, 2015). The brain-behavior relationship began to unfurl as data was gathered 
through testing, medical, surgical, and autopsy channels and the field of neuropsychology 
was born. Reitan’s work: 
…refined and standardized what most neuropsychologists now take for 
granted as they write their reports: the approach to inference in individual 
cases that takes into account such information as levels of performance, 
patterns of test results, right-left comparisons, and pathognomonic signs. 
(Grant & Heaton, 2015, para. 3) 
The Halstead-Reitan battery is a collection of NP tests that assess the functioning of the 
brain and is still used both in its complete form and as individual test components today.  
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The Role of Neuropsychological Testing in Clinical Settings 
NP testing and measurement play an important role in diagnosis, prediction of 
progression, and treatment planning for neurodegenerative diseases because research 
demonstrates that these actuarial methods are superior to clinical judgment alone (Smith & 
Bondi, 2013). The FDA established cognitive measures in this critical role when they 
required NP measures be included as a co-primary outcome in research studies seeking to 
demonstrate efficacy in dementia treatments (Leber, 1990). A test is defined as any set of 
tasks, procedures, or stimuli designed to elicit responses that sample an examinee’s 
performance or behavior in a specified domain, while assessment is the broader term 
referring to the process that integrates the gathered data with other sources of evidence 
such as interviews about a participant’s social, educational, employment history, health 
history, and psychological history (AERA, APA & NCME, 2014). NP testing batteries 
gather quantified and meaningful data about an individual’s various cognitive and 
behavioral domains for diagnostic or predictive value, yet the final diagnosis should 
always include a full assessment including physical and neurological examinations, the 
patient’s medical and family history, and blood tests or brain imaging to rule out other 
potential causes of cognitive impairment.  
As there is no single test for dementia, a variety of different measures are used 
during an assessment to take an inventory of the strengths and weaknesses of the major 
cognitive domains including verbal and nonverbal IQ, memory domains that encompass 
both encoding (learning) and retention (delayed recall and recognition), executive function 
processes, language production, attention, visuospatial skills, and processing speed. The 
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patterns and profiles attained from testing aid in a differential diagnosis between the 
underlying pathologies (Karantzoulis & Galvin, 2011; Ramirez-Gomez et al., 2017; 
Ramlall et al., 2014; Smith & Bondi, 2013; Stephan et al., 2017).  
Normal aging individuals have no deficits on psychometric test performance 
relative to their age-matched peers, whereas individuals “at risk” for dementia may have 
borderline or impaired cognitive function in one or more areas of cognition when 
compared to age-matched peers. Ideally, more than one measure is used in each domain so 
that evidence converges to illuminate the relationship between tests intended to assess 
similar constructs. This also helps assure that discriminant evidence between measures 
intended to measure different constructs are also accurate. Educational and psychological 
testing methods are some of the most significant and vital contributions of the behavioral 
sciences to society (AERA, APA & NCME, 2014). The procedures for neuro-
psychological testing and data collection are highly operationalized and demonstrate 
strong reliability (Ramirez-Gomez et al., 2017; Smith & Bondi, 2013).  
Tests that are valid for their intended purposes provide substantial benefits 
for test takers and test users…proper use can result in better decisions 
about individuals and programs than would result without their use... The 
improper use of tests, on the other hand, can cause considerable harm to 
test takers and other parties affected by test-based decisions. (AERA, APA 
& NCME, 2014, p.1)  
A primary consideration in developing and evaluating tests is validity, an 
accumulation of evidence that scientifically supports that the test measures the construct 
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it is intended to measure. The validity and reliability of testing methods are the 
foundation for accurate assessment (AERA, APA & NCME, 2014; Heaton et al., 2004). 
The first empirical paper published in the Journal of Applied Psychology in 1917 was a 
validation study by Terman and his colleagues (Cortina et al., 2017). The process of 
validation deliberates arguments both for and against the intended interpretation of the 
test scores relevant to their proposed use (AERA, APA & NCME, 2014). The validation 
process is continual, constantly evolving as new data is gathered, and often necessitates 
revisions to accommodate the latest articulated evidence (Wilkenson & Robertson, 2006). 
The proposed study is a concurrent study, particularly useful for psychodiagnostic tests 
(AERA, APA & NCME, 2014). It also continues the validation process of the measures 
being used and may provide evidence to refine and reevaluate the utility of the tests and 
their interpretations for use in an aging population.  
 Smith and Bondi (2013) asserted that NP measures are essential in clinical and 
research efforts focused on neurodegenerative disease and defined five roles for such 
measurements in preclinical and clinical dementia populations. First, NP measures serve 
as biomarkers because they are highly operationalized and help distinguish between 
underlying pathologies (Smith & Bondi, 2013). The FDA’s requirement that cognitive 
measures must be included as a co-primary outcome in secondary prevention studies 
solidified NP measures in this key role (Smith & Bondi, 2013). Second, they serve as 
predictors for the development of AD and other dementias; they detect the clinical 
manifestations of neurodegenerative disorders, so they should also predict their future 
development (Smith & Bondi, 2013). 
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Third, measures can dynamically capture countervailing influences on disease trajectory, 
studies suggested that memory function does not decline at an even rate but goes through 
periods of stabilization that may reflect biological and psychological compensatory 
mechanisms such as the mediating and moderating factors of compensatory strategies or 
cognitive reserve (Smith & Bondi, 2013). Fourth, NP measures are proxies for important 
functional deficits; patients may be unreliable reporters of their own functional , so the 
measures serve to estimate functional impairment which helps family members determine 
what matters most, because it identifies when their loved one is no longer safe living 
independently (Smith & Bondi, 2013). Finally, NP measure can provide insights into 
interventional targets (Smith & Bondi, 2013). Just as important as identifying impaired 
cognitive domains, measurements also have the ability to identify cognitive domains with 
preserved strengths. Cognitive rehabilitation services can capitalize on an individual’s 
residual strengths in order to compensate for weaker areas. These five functions demand 
that the NP measures contain the optimal sensitivity and specificity for their intended 
purpose.  
A test that is sensitive to detecting a neurodegenerative disease like AD must have 
a high probability that patients with AD score in the abnormal range, while higher 
specificity assures that patients without dementia will score within normal range. Smith 
and Bondi (2013) argued that positive predictive value rather than sensitivity, is 
statistically more relevant to a diagnostic situation, and enhancements to specificity are 
more important for this purpose. The use of norms is assumed to enhance specificity. 
Researchers argue that aging is the major risk factor for dementia, therefor it undermines 
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the sensitivity of NP measures to control for age (Hessler et al., 2014; Holtzer et al., 
2008; Malek-Ahmadi et al., 2015; O’Connell & Tuokko, 2010; Quaranta et al., 2016). 
The current study will obtain empirical evidence and conduct logical analyses to evaluate 
the proposition that age- and education-corrected norms may not universally improve 
utility of testing measures in an aging population. 
Norm-Referenced Interpretation in Neuropsychological Assessment 
Educational and psychological testing theory assumes the concept of an “ideal” or 
“normal” level of functioning against which the test taker’s performance can be 
compared. Therefore, the most fundamental level of interpretation is the participant’s 
performance in relation to the general population as established by a standardized sample 
to derive normative scores (AERA, APA & NCME, 2014; Heaton et al., 2004). Raw 
scores, simply the number of items correct on any given test, are thought to be of little 
use because tests vary in difficulty and the number of items they contain, making it 
difficult to make meaningful comparisons to other scores (AERA, APA & NCME, 2014; 
Bryant & Brown, 1984; Schoenberg & Scott, 2011). Therefore, derived scores, a 
statistical concept illustrating the participant’s exact position relative to individuals in the 
normative group, has become a far more meaningful and significant metric. Norms 
provide a point of reference that make raw scores valuable by allowing interpretations 
that indicate if the individual’s performance is typical for the normative group. They also 
allow for comparison of performance across various tests, track change or progress across 
time, and diagnose strengths and weaknesses (Bryant & Brown, 1984; AERA, APA & 
NCME, 2014; Schoenberg & Scott, 2011). Thus, norm-referenced interpretation has 
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become gospel in testing theory (Quaranta et al., 2016). One of the fundamental 
principles relevant to norming is the selection of the appropriate comparison group for 
the tests being used.  
At a most basic level, a normative sample is taken from the population that is 
thought to be large enough to represent the current U.S. population, and sufficient enough 
to be proportional across certain demographic characteristics such as sex, age, and level 
of education, geographic region, and race or ethnicity. The mean score becomes the 
average and expected level of performance for age and education. High scores are 
classified in terms of being “high average”, “superior”, and “very superior”, while low 
scores are described in terms of “low average”, “weak/mildly to moderately impaired”, 
and “exceptionally weak/severely impaired”. The use of demographically corrected 
normative scores is recommended for most diagnostic purposes. Yet, despite the quest to 
achieve a fair representation in a normative sample, researchers established that there are 
times when it may be advantageous to develop norms based on the performance of 
individuals in a specific subpopulations; especially if the mean of the subgroup is 1 to 1½ 
SD away from the mean of the normative group, or when test performance is tied to a 
specific therapy or treatment (Bryant & Brown, 1984; Hessler et al., 2014; Holtzer et al., 
2008; Malek-Ahmadi et al., 2015; O’Connell & Tuokko, 2010; Svinicki & Tombari, 
1981). This study examines whether late adulthood, a time of exponentially increased risk 
for cognitive impairment, may be one of the exceptions to the standard practice of using 
an age- and education-corrected normative system.  
61 
 
Methods of Norming 
Both educational and psychological testing assume a “normal” level of functioning, 
which is traditionally established by the mean test performance in the standardization 
sample. The most fundamental interpretation of an individual’s performance is their 
standing in relation to the general population. When the individual’s raw score is compared 
to the distribution of scores across the sample population, it becomes a snapshot of where 
they fall in that distribution. This gives clinicians and researches a uniform frame of 
reference to determine the individual’s relative position within the context of the larger 
population. Understanding the principles relative to developing norms is imperative for the 
test user as “psychological test norms are in no sense absolute, universal, or permanent” 
(Anastasi & Urbina, 1997, p. 68).  
The main consideration in traditional norming methods is representativeness of 
the standardization sample to the general population, but it is equally important that the 
sample represent the population using the test (Anastasi & Urbina, 1997). Data should be 
collected at multiple sites that represent different geographic regions of the U.S. The 
advantage of traditional norming is its simplicity, but the greatest disadvantage is that 
separate norm groups must be defined arbitrarily for continuous covariates like age and 
as a result can change an interpretation of an individual’s test performance; a corrective 
measure would be to define more categories, but the smaller sample size produces less 
precise norms (Oosterhuis, et al., 2016). Zachary and Gorsuch (1985) introduced linear 
regression to avoid categorizing continuous covariates. According to Oosterhuis et al. 
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(2016) regression-based norming, which requires a smaller sample size but claims 
equally precise norms is gaining in popularity.  
It has been established that participants should be screened and excluded for 
characteristics that might interfere with their performance such as sensory impairment, 
brain impairing medications, or a medical history that includes stoke, epilepsy, or any 
other neurological issues that affect cognition (White & Stern, 2003), but in an aging 
population this is a difficult task. Robust norms, norms that follow the normative cohort 
for a length of time removing anyone who develops dementia and keeping only those 
who remain dementia free, may have more clinical utility than conventional norms when 
dealing with an aging population (Holtzer et al., 2008). Hassenstab et al. (2016) found 
that removing preclinical participants from normative samples yielded higher means and 
less variability on episodic memory, visuospatial ability, and executive function measures 
reducing age-affects, but provided no substantive benefit for diagnostic classification. 
However, the considerable investment of resources needed to establish robust norms 
leaves researchers looking for alternative methods to estimate the prevalence of 
preclinical cases and consequentially adjust interpretation guidelines for cognitive testing.  
Norm-Referenced Interpretation in MCI and Dementia 
Norms are assumed to enhance specificity, the probability that a person without 
dementia will have normal test scores. But because age is the number one risk factor for 
dementia, researchers currently debate the use of norms in an aging population arguing 
that norms reduce the sensitivity of the test scores to abnormal cognitive impairment 
(Hessler et al., 2014; O’Connell & Tuokko, 2010; Quaranta et al., 2016). There are 
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several reasons stated why this may be true. It is noted in the literature that norms 
become less accurate as time between publication and use increases due to changes in 
demographics and socioeconomic factors that modify the composition of the reference 
population (Quaranta et al., 2016). It is also argued that individuals in the normative 
sample population for age corrected norms may already be transitioning into dementia 
and contaminating the norms by lowering the mean performance and increasing the 
variability in cross-sectional samples (Holtzer et al., 2008). Late adulthood is also a time 
when brain impairing maintenance medications are routinely prescribed to manage 
chronic health conditions. Age correction is also thought to decrease the sensitivity of 
measures because norms become more forgiving and tolerant of errors as age increases, 
possibly decreasing the sensitivity of the tests to cognitive impairment and 
underestimating the risk of dementia in our aging population (Smith & Bondi, 2013). 
Optimal demographic correction as determined via the analyses in this study could result 
in better diagnostic performance when differentiating normal controls from individuals 
with dementia when employing cognitive testing.  
Summary 
It is recognized that symptoms of dementia may not appear for 20 years or more 
after brain changes start to occur (Jack et al., 2015; Ritchie et al., 2015; Rockwood et al., 
2014; Smith & Bondi, 2013; Sperling et al., 2011; Sutphen et al., 2015; Ward et al., 
2013). Research is only beginning to address how many people may be in preclinical 
stages of dementia or have MCI due to neurodegenerative diseases (AA, 2018) and these 
individuals are included in the standard norms which influence a diagnostic outcome 
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when employing a NP testing perspective. Smith and Bondi (2013) asserted the number 
of patients that can be helped through neuropsychology is only increasing and the ability 
to differentiate between normal aging, dementia, and the phase between the two, accepted 
as MCI, has emerged as a primary focus of research.  
Psychometric measures are the necessary tools that provide the data needed to 
distinguish between normal aging and a neurodegenerative process (Smith & Bondi, 
2013). As there is no single measure for dementia, the continued validation of current 
measures to optimize their ability to differentiate between normal cognitive aging and a 
neurodegenerative disease process is paramount. There is no cure for AD and the race 
against the clock continues to inspire researchers to search for new ways to diagnose the 
condition earlier and more accurately. Treatments and interventions must be administered 
as early as possible if there is any hope of changing the course of the disease. Researchers 
argue that outcome studies using comprehensive actuarial methods to examine the 
patterns and profiles of NP dysfunctions are needed to move the field forward (Bondi et 
al., 2014; Malek-Ahmadi et al., 2015, Smith & Bondi, 2013). The current study aims to 




Chapter 3: Methodology 
The following methodology was review and approved by the Walden University 
IRB, approval number 01-21-20-0529160. The overarching purpose of this study was to 
investigate the impact of demographic corrections on the diagnostic validity of cognitive 
tests in differentiating between normal cognitive aging and dementia. The standard 
practice of demographically correcting raw test scores for age and education is widely 
believed to universally improve the scores’ ability to detect cognitive impairment for all 
age groups. However, there is a debate in the literature about the use of demographically 
corrected scores in our aging population because the norms for older individuals may be 
tainted by individuals with preclinical AD and thus underestimate the presence of 
cognitive impairments. Consequently, it is not clear how to best use normative data in 
dementia evaluations. This section is an exposition of the data and the analytic strategies 
that will be used for this investigation. 
First, the methodology and rationale is introduced along with a brief review of 
how clinicians determine the presence or absence of dementia. Next, participant selection 
procedures, recruiting strategies, and data collection techniques designed to minimize 
threats to internal validity are addressed. The primary variables involved in the analysis 
are presented, and the manner in which demographic corrections were applied and the 
creation of aggregate cognitive composite scores from individual tests follows. The data 
sources are thoroughly explained, including a review of the reliability and validity of the 
tests taken from the most recent version of the UDS-3 NAB, with special attention paid to 
the CDR-SB the primary criterion measure in the study. Subsequently the detailed data 
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analysis plan that was used to investigate primary study hypotheses (including 
assumption testing and regression diagnostics that protect against threats to internal and 
external validity) are presented. Finally, a priori power analysis for tests of the overall 
models was generated, and the regression coefficients are disclosed.  
Hierarchical multiple linear regression was used to investigate the strength of the 
relationship between the patient’s test scores (scored 4 different ways) and the patient’s 
clinical dementia severity rating. Because the order of entry into the hierarchical multiple 
linear regression model can have great impact on the results, the order of variable entry 
was defined a priori, which avoided pitfalls inherent in methods such as stepwise 
regression and will promoted better generalization as opposed to overfitting of sample 
data (Harrell, 2001; Roa, 2003). Comparison of the R2 and AIC values of the various 
regression equations clarified the extent to which the raw scores, or the various types of 
demographic corrections (e.g., age, education, age and education) influenced the ability 
of cognitive tests to detect meaningful variation functional changes due to cognitive loss 
in dementia and MCI. While this cannot be explicitly tested for significance because 
there are no universally accepted means for quantitatively comparing non-nested models, 
it was one of the more important features of this study. Differences in R2 and AIC values 
of the various regression models allowed for quantitative analysis of model differences, 
albeit not with a specific statistical test. 
Determining the Presence or Absence of Dementia  
The primary difference between dementia and MCI is the extent to which the 
cognitive decline influences the individual’s day-to-day functioning (APA, 2013; 
67 
 
McKhann et al, 2011). MCI requires an objectively determined decline in cognitive 
function as evidenced by mental status screening or formal NP testing in the setting of 
relatively well-preserved day-to-day functioning (APA, 2013; Albert et al., 2011). 
Dementia by definition requires significant functional impairment that represents a 
decline from the individual’s previously higher level of functioning (APA, 2013; 
McKhann et al, 2011). Heuristically and in clinical practice, this is often defined as the 
loss of ability to independently complete IADLs (e.g., driving, managing one’s finances, 
self-managing medications, using the community, etc.) with an adequate performance 
level. More formally, global staging instruments such as the CDR measure the extent to 
which cognitive loss interferes with an individual’s ability to perform day-to-day 
activities (Morris, 1997). The CDR measure represents the ultimate quantitative standard 
for the presence or absence of dementia and thus serves as an optimal criterion for the 
purposes of the present study.  
Study Variables 
The primary variables involved in the analyses presented below included the CDR 
as an outcome measure, a global measure of dementia severity that has been 
neuropathologically validated and is considered an international “gold-standard” for 
ascertaining the presence or absence of dementia (Olde-Rikkert et al., 2011). The CDR 
also allows clinicians to derive the CDR-SB by summing clinician ratings in the 6 
different domains, which provides a more fine-grained, pseudo-continuous measure of 
dementia severity. Published criteria derived from large clinical samples exist for 
determining the presence or absence of dementia using either the global CDR score 
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(Morris, 1993) or the CDR-SB (O’Bryant et al., 2008, 2010). Individuals with a CDR-SB 
of 0 are considered “normal,” those with a CDR-SB of 0.5 - 2.5 are considered to have 
“questionable impairment,” those with a CDR-SB of 3 - 4 are considered to have “very 
mild dementia,” whereas individuals with a CDR-SB of 4.5 - 9.0 are considered to have 
“mild dementia.” The predictor variables were derived from a subset of the tests from the 
UDS-3 NAB. The memory domain was represented by Craft Story immediate and 
delayed recall and Benson complex figure delayed recall. The executive function domain 
was defined by verbal fluency (F & L) and the Trail Making Test B. The language 
domain was defined by the Multilingual Naming Test (MINT) and semantic fluency 
(Animals). And Digit Span Forward (DGF) and Digit Span Backward (DGB) backward 
were used to define the attention domain. Additional clinical and demographic variables 
needed to process the data, such as etiologic diagnosis, age, education, gender, and visit 
number were also utilized  
Participant Selection and Stratification 
Most individuals with Alzheimer’s disease develop the condition later in life, but 
Alzheimer’s can develop in a subset of individuals any time after the second decade of 
life (Rossor et al., 2010). Classically, Alzheimer’s dementia is considered “early onset” 
or “young onset” when it develops prior to age 65. While this threshold is somewhat 
arbitrary, there is a large body of evidence suggesting that individuals with early-onset 
AD often present with atypical forms of the illness and different cognitive profiles 
characterized by more visuospatial disturbance, executive dysfunction, and higher rates 
of behavioral or neuropsychiatric disturbance (Ossenkoppele et al., 2015). The primary 
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goal of this study was to inform the clinical use of NP tests in the types of situations most 
commonly encountered by professionals in clinical practice. Accordingly, all subjects 
younger than 60 years of age were excluded from analysis in order to increase the 
likelihood that the study sample was most reflective of typical presentations of AD. 
Similarly, different dementia subtypes present with different degrees and types of 
cognitive difficulties. For example, dementia due to Lewy body disease is classically 
thought to present with early visuospatial and constructional impairments while memory 
may remain preserved until well into the disease course (Karantzoulis & Galvin, 2011). 
Inclusion of non-Alzheimer’s dementia may thus introduce phenotypic-related variability 
that would obscure detection of subtle differences due to demographic factors. 
Accordingly, only individuals with a primary etiologic diagnosis of AD were selected 
from the data set for analysis. Dementia due to AD is a progressive condition and 
individuals traverse several stages during the course of the illness. NP tests may be most 
helpful in the earlier phases of disease (e.g., MCI, Mild Dementia), as patients become 
too cognitively impaired to participate meaningfully in assessment as they transition from 
mild to later stages of dementia. There is also a high likelihood that cognitive test data 
from moderate to severely demented patients may be less reliable and thus less 
meaningful than in individuals with milder forms of the disease (Weintraub et al., 2018b). 
For example, attention, language, memory, and executive function test results may be 
substantially influenced by general confusion, language comprehension problems, 
difficulty appropriately engaging in the task, or other impairments that render cognitive 
tests unreliable indicators of the processes they are purported to measure. Accordingly, 
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individuals with a CDR-SB > 9 (i.e., moderate to severe dementia) were removed from 
all analyses.  
Creation of Cognitive Composites 
Most studies addressing the effects of age and education correction on the 
predictive validity of cognitive tests in dementia have focused on single test scores 
(Sliwinski et al.,1996; Sliwinski et al., 1997) or heterogenous composite scores 
representing multiple cognitive domains (Hessler et al., 2014). It is likely that age and 
education correction influence different cognitive domains differently. For example, 
processing speed invariably declines with increasing age (Eckert, 2010) whereas 
crystallized abilities such as vocabulary or fund of knowledge remain stable or even 
improve throughout senescence (Harada et al., 2013). A novel feature of the present study 
was the creation of domain-specific cognitive composite scores for memory, executive 
function, language, and attention that allowed for precise investigation of the extent to 
which age and education affected the predictive validity of individual cognitive domains 
using a hierarchical multiple linear regression analysis.  
Creation of cognitive composites was also advantageous statistically. Composite 
measures may be more sensitive to longitudinal cognitive changes in preclinical dementia 
and more reliable than the measures from which they are derived (Riordan, 2017). 
Cognitive composites also offer a better and more complete sampling of participant 
cognitive abilities than do single cognitive test scores by virtue of their broader item 
content. Models with fewer explanatory variables are also more desirable than complex 
models due to enhanced interpretability (James et al., 2017). Such models also tend to 
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demonstrate less variance across samples, which increases the likelihood that they will 
generalize to new samples. Composite scores can generally be categorized as empirically 
derived, theoretically derived, or some combination of these two methods (Weintraub et 
al., 2018b). This project made use of a theoretically driven strategy that is grounded in 
well-established principles of NP function and localization. The method used for 
aggregation of tests within a domain has been widely used as exemplified by Donohue et 
al. (2014) and involves first grouping tests into different cognitive domains, transforming 
scores to the same metric (i.e., Z-scores), and then summing them to create aggregate 
cognitive composite measures with similar psychometric properties and scales of 
measurement. Theoretical groupings of the particular tests used in this study into 
different cognitive domains (memory, executive function, language, and attention) are the 
same as in Weintraub et al. (2018a). 
Impairments in memory and executive functioning are highly characteristic of the 
cognitive phenotype associated with typical presentations of AD  (Karantzoulis & Galvin, 
2011). Memory measures in particular have been shown to be some of the earliest 
indicators decline, even in minimally symptomatic individuals (Weintraub et al., 2018b). 
Tests in this domain included Craft Story immediate and delayed recall and the Benson 
complex figure delayed recall. The executive function domain included verbal fluency (F 
& L) and Trail Making Test B. Impairments in language including deficits in semantic 
verbal fluency and visual object confrontation naming are also characteristic of AD 
(Salmon & Bondi, 2009). This domain was constructed using the Multilingual Naming 
Test (MINT) and semantic fluency (Animals). Individuals with AD may additionally 
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show difficulties with attention and working memory, though these abilities are often 
better preserved until later into the illness (Cherry et al., 2002). Digit Span Forward 
(DGF) and Digit Span Backward (DGB) backward were used to create the attention 
domain. Following transformation of raw scores into Z-scores using the various norming 
methods described in the following section, Z-scores were summed across tests within a 
given cognitive domain to create a composite score for each domain. These composite 
scores served as the predictor variables in the series of hierarchical regression analyses. 
Cognitive Test Scoring 
Subjects’ raw test scores were analyzed before and after a series of demographic 
corrections. Cognitive tests are scored on different metrics (i.e., seconds to completion as 
opposed to number of words remembered) and thus must be transformed to a common 
scale in order to facilitate comparison. Weintraub and colleagues (2018b) developed a 
normative calculator for the UDS-NAB through fitting linear regression models to the 
cognitive test data of 3602 cognitively normal participants over the age of 60. 
Specifically, cognitive test scores were predicted using age, gender, education, and the 
combination of these variables. These regression models can then be used to standardize 
observed test scores, adjusting for the demographic variables of choice.  
The intercepts of the regression models represent the mean performance of the overall 
study sample holding age and education constant. The root mean squared error (RMSE) 
represents the average squared difference between the observed scores and the predicted 
scores, which can be used as a surrogate measure of the population standard deviation 
(Weintraub et al., 2018b). To facilitate comparison between the models, the intercept, 
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slope, and demographic variable regression weights from the full model incorporating 
age, sex, and education will be utilized and thus, all analyses were corrected for gender.  
To generate “raw scores,” subjects’ scores were first transformed into Z-scores by 
generating predicted scores using each subjects’ actual gender, the average education and 
age level of the overall sample, subtracting the predicted score for a participant from their 
observed score, and then dividing by the RMSE of the model. There were no systematic 
adjustments for age or education, allowing the variability of those factors to remain in the 
model. To generate age-corrected scores, participant scores were transformed as above 
but with an adjustment for age by multiplying the participant’s actual age by the 
coefficient for age when generating the predicted scores. To generate education-corrected 
scores, the same procedure was applied but with an adjustment for each participant’s 
actual education level. To generate age- and education-corrected scores, subjects’ actual 
age and education was used to generate predicted scores.  
The National Alzheimer’s Coordinating Center Uniform Data Set 3 
NACC was established by a division of National Institutes of Health. NACC’s 
ultimate goal is to provide a comprehensive approach to research on AD (Besser, 2018). 
To date, there are 39 present and past ADCs. In 2005, the ADCs began longitudinally 
collecting demographic, clinical, NP, and diagnostic data on the original version of the 
UDS (Morris et al., 2006). Version 2 was implemented in 2008, which represented a 
minor update to data collection elements including several new forms, restructuring the 
form logic, and adding a few NP test elements. The 3rd and most recent revision of the 
Uniform Data Set (UDS-3) represents a major advance, including a fully updated NP test 
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battery, additional supplemental data, and updated diagnostic criteria to reflect changes in 
how dementia syndromes are classified in current clinical practice. Data collection with 
the UDS-3 was implemented in March 2015. As of the most recent data freeze in March 
2019 approximately 6, 266 individuals in the UDS 3 had completed the UDS-3 NAB. 
Further details regarding the study sample are available at: 
www.alz.washington.edu/WEB/UDS_NEUROonepage.pdf.  
Each ADC enrolls subjects according to its own protocol. Subjects may come via 
clinician referral, self-referral by the patient or family members, active recruitment 
through community organizations, or by volunteering. In addition to patients with 
dementia and mild cognitive impairment, most centers also enroll normal control 
participants. As such, the NACC subjects are not a statistically representative sample of 
the U.S. Population. They are best described as a referral-based or volunteer case series. 
This renders UDS data inappropriate for studies of the prevalence or incidence of 
dementia. UDS data are collected via standardized evaluation of subjects enrolled in the 
ADCs. Data are generated using a standard order of administration for the NP tests, 
collected by trained clinician and clinic personnel, and diagnosis is made by either a 
consensus team of multiple practitioners or a single physician dependent upon the 
individual ADCs protocol. Subjects are seen for an initial visit and followed 
longitudinally with approximately annual visits until they can no longer participate or are 




Clinical Dementia Rating  
The CDR is a dementia severity rating that is clinician administered, structured 
interview of a patient and a knowledgeable informant (often a family member) that can 
be conducted by a physician, nurse, social worker, or other trained staff member (Morris, 
1997). Following the interview, clinicians rate a patient’s functioning in the areas of 
memory, orientation, judgment and problem solving, function at home and hobbies, 
function in the community, and personal care. A global score can be calculated based on 
published scoring rules and used as a gross summary measure of dementia severity, but 
the CDR also allows clinicians to derive the CDR-SB which provides a more fine-
grained, pseudo-continuous measure of dementia severity. Published criteria derived 
from large clinical samples exist for determining the presence or absence of dementia 
using either the global CDR score (Morris, 1993) or the CDR-SB (O’Bryant et al., 2008, 
2010). The CDR was developed by John Morris and colleagues at the Washington 
University in St. Louis ADC in the 1980s (Hughes et al., 1982). It has since become the 
dominant global staging measure used clinically, in research, and as a primary end point 
in clinical trials. It has been translated into 14 different languages and was described as 
the “best-evidenced” measure in a recent review on global dementia severity staging 
measures (Olde-Rikkert et al., 2011). The CDR has been neuropathologically validated 
and demonstrates predictive accuracy of 92% for the presence of Alzheimer’s pathology 
in symptomatic individuals with AD (Storandt et al., 2006). Studies indicate high 
interrater reliability for physicians and non-physicians applying the CDR (Williams et al., 
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2013). Accordingly, the CDR was an ideal criterion measure for the purposes of the 
present study.  
Craft Story 21 
 The trademark characteristic of AD is memory loss, so list learning and story 
memory tasks are frequently used in the episodic memory evaluation for dementia. Craft 
and colleagues designed a story recall test with multiple forms that achieved similar 
psychometric properties to the Weschler Logical Memory test, immediate and delayed 
recall conditions (Weintraub et al., 2018a). The complete set of stories consisted of 22 
narratives that were originally tested on 13 healthy adults and 22 patients with 
Alzheimer’s dementia and rated on the CDR as very mild, mild, moderate, and severe 
(Craft et al., 1996). Participants listened to a brief story with 25 bits of information and 
were asked to recall both immediately and after a 10-minute delay, receiving credit for 
each bit of data that was recalled verbatim or accurately paraphrased. Validity was 
determined by correlation with The Wechsler Memory Scale normative scores: 
 Pearson r’s between Logical Memory and paragraph recall scores were 
0.73, p < 0.02 (immediate recall) and 0.84, p < 0.004 (delayed recall) for 
normal adults and 0.76, p < 0.0002 (immediate recall) and 0.88, p < 0.0001 
(delayed recall) for Alzheimer patients. Group mean and SD were nearly 
identical. (Craft et al., 1996, p. 126)  
When the Neuropsychology Work Group committee convened to make recommendations 
for the UDS-NAB 3, their pilot study to determine the equivalence of the stories in 
middle-aged and older adults determined that 3 of the stories offered the greatest 
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relationship to the Logical Memory subtest of the Weschler Memory Scale and to each 
other, with a single story chosen because of its applicability to a culturally diverse 
population and “Craft Story 21” was adopted as the episodic memory measure for UDS-
NAB 3 (Weintraub et al., 2018a). In this study, the composite score for the memory 
domain was composed of the scores from Craft Story 21 and the Benson Complex Figure 
recall task.  
Benson Complex Figure 
Asking a patient to copy a figure is the most common method of assessing 
visuospatial ability in dementia evaluations and having the patient recall the figure after a 
delay is considered a measure of nonverbal memory. These tasks are new addition to the 
UDS-NAB 3. Impairments in the visuospatial domain commonly appear in AD, bvFTD, 
and DLB. Complex figure copy tasks like the Rey-Osterrieth Complex Figure are 
influenced by visual spatial perception and attention, and also frontally mediated 
executive skills like organization, strategic planning, and working memory (Possin, 
Laluz, Alcantar, Miller & Kramer, 2011). The Rey Complex Figure Test was developed 
by Rey in 1941 and has a long history in neuropsychology (Strauss et al., 2006). Internal 
reliability was evaluated by split-half and alpha coefficients and achieved greater than .60 
for copy trial, and greater than .80 for recall trial. Test-retest reliability examined (r = .76; 
r = .89) for immediate copy and delayed recall respectively (Strauss et al., 2006). Validity 
is also supported through independent correlational and factor analytic studies (Meyers & 
Meyers, 1995). The Benson Figure is a simplified variation of the Rey-Osterrieth figure 
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developed by Frank Benson (Possin et al., 2011) and was adopted as a measure of 
visuospatial ability and memory recall in the UDS-3 NAB.  
Phonemic Fluency 
 Verbal fluency tests assess the spontaneous production of individual words under 
constrained conditions. Phonemic fluency tasks (“F” and “L”) are commonly used in 
many NP batteries (Strauss et al., 2006). Originally developed as a measure of primal 
mental abilities by Thurstone in 1938, his variant of the word fluency test showed 
performance improved throughout childhood, peaked about age 30-39, and mildly 
declined into old age in normal cognition. This pattern was confirmed by subsequent 
research, and accumulating evidence showed that the test was highly useful for the 
detection of dementia because it is heavily dependent on the integrity of executive 
function (Strauss et al., 2006).  
The letters F, A, and S are most commonly used, but C, F, and L are also used. 
The examinee is given the specified letter, in this case F and L, and orally produces as 
many words as possible in 1 minute. The total score is the sum of all correct words for 
both letters. Alternate form reliability observed correlations among phonemic fluency 
tasks high (.85 to .94) with differences between letter sets small (Strauss et al., 2006). For 
a detailed discussion of letter equivalence across different versions see Borkowski, 
Benton and Spreen (1967). Studies indicated test-retest correlations typically .70 or 
higher for letter and fluency at both short (2 week) and long (5 year) intervals (Strauss et 
al., 2006). Age and education corrected norms are published in manuals (Heaton et al., 
2004), and can be statistically computed (Mitrushina et al., 2005; Tombaugh et al., 1999). 
79 
 
For the purpose of this study, verbal fluency F & L and TMT B were chosen as measures 
of the executive function domain.  
Trail Making Tests B 
 The adult version of the Trail Making Tests (TMT) measures processing speed in 
people aged 15 to 89. Originally constructed in 1938 as a divided attention test, they were 
part of the Army Individual Test Battery and adapted by Reitan in 1955 (Strauss et al., 
2006). Scoring is expressed in seconds required to complete the test with a maximum 
time on TMT B set at 300 seconds. Performance is affected by age, education, and IQ; 
with education becoming progressively more important with increasing age. Test-retest 
reliability was high in healthy controls (r = .89) for TMT B; but not uniformly reliable in 
clinical groups (r = .67 to r = .86); practice effects noted in healthy controls leveled off 
after 5 administrations (Strauss et al., 2006). Alternate form reliability reported a 
reliability coefficient of .92. Validity was demonstrated through correlations with other 
measures of executive processing speed including the Category Test; Wisconsin Card 
Sorting Test; Visual Search and Attention Test; Symbol Digit Modality Test; Paced 
Serial Addition Test; and Letter Cancellation that were moderate to strong (.36 to .93) 
with TMT B emerging as more sensitive to executive control (Strauss et al., 2006). Thus, 
TMT B was chosen to be included in the composite measure of executive control 
function.  
The Multilingual Naming Test  
 Individuals with AD show deficits in naming speed and accuracy (dysnomia). The 
Boston Naming Test is one of the most common measures of confrontation naming 
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(Kaplan et al., 1983) and has been shown to discriminate well between cognitively 
normal participants and those with dementia (Katsumata et al., 2015). The MINT was 
specifically designed to be a culturally sensitive measure of picture naming for English, 
Spanish, Mandarin Chinese, and Hebrew. Sixty-eight black-and-white line drawings, 
selected from a variety of sources with translation equivalents in each different language, 
are presented in increasing difficulty of order. Ivanova et al. (2013) found the MINT was 
highly correlated with the BNT, ranging from r = .855 to r = .893, p < 0.001, and 
suggested that it had more utility for diagnostic purposes as the BNT was biased in favor 
of English. Ivanova et al. (2013) established that a 32-item subset of the MINT had 
adequate sensitivity and provided superior clinical utility because of its contextual 
diversity to detect naming impairments in AD and controls. 
The NP Work Group replaced the Boston Naming Test (BNT) with the MINT for the 
UDS-NAB 3 (Weintraub et al., 2018a). This study used the MINT and Animal Fluency 
as the measures for the Language domain. 
Animal Fluency 
The most common semantic fluency test requires an individual to name as many 
animals as possible in 1-minute, other categories such as fruits and vegetables or “things 
to wear” are also used (Strauss et al., 2006). Norms were derived from large samples of 
participants that ranged in age from 20 to 101 years of age depending on the study; (n = 
1148) in Heaton et al. (2004); (n = 2843) in Mitrushina et al. (2005) and (n = 735) in 
Tombaugh et al. (1999) to name just a few. Tombaugh et al. (1999) found the degree of 
internal consistency high (r = .83) and test-retest reliability coefficient of .74 after a 5-
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year interval in elderly individuals. Studies showed test-retest correlations were typically 
.70 or higher for semantic fluency at both short (2 week) and long (5 year) intervals 
(Strauss et al., 2006). Like phonemic fluency tasks, age and education corrected norms 
are located in published manuals (e.g., Heaton et al., 2004) and can be statistically 
computed (Mitrushina et al., 2005; Tombaugh et al., 1999). 
Digits Forward and Digits Backward 
DGF assess attentional capacity using auditory digit repetition, a common method 
used in most existing tests for this purpose. DGB requires the examinee to reverse orally 
presented digits as a measure for both attentional capacity and working memory. The 
number strings are administered up to failure of two trials at the same length with points 
earned for each completed sequence and, in some cases, a note for the longest digit span 
completed. Digit span tasks are modeled after the Weschler Memory Scale III (WMS), 
which was originally designed to assess auditory attention and working memory (Strauss, 
2006). The number spans for the UDS-NAB 3 were randomly generated with the 
restriction that no digit would be adjacent to the next higher or lower digit, and efforts 
made to avoid recognizable sequences such as common area codes (Weintraub et al., 
2018a). Digit span generalizability coefficients to the WMS were high (.80 to .89), and 
while ‘clinical lore’ espouses that DGB is more demanding of working memory than 
DGF and more sensitive to advancing age and neurodegenerative conditions, the most 
recent findings suggest that both DGF and DGB are affected equally as one ages, 
although large discrepancies between the two tasks may point to a deficiency in working 
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memory (Strauss et al., 2006). DGF and DGB served as our measures of the attention 
domain.  
Data Analysis Plan 
The following section describes the analytic strategies that will be used to answer 
the primary study hypothesis, data cleaning (e.g., handling of outliers and missing 
values), construction of hierarchical linear regressions to test primary study hypotheses, 
and an a priori power analysis. Prior to that discussion, it may be helpful to restate the 
series of regression analyses that are planned, and the primary study hypothesis and sub-
hypotheses. This study involved predicting the CDR-SB score by a combination of 
cognitive composite scores derived from cognitive tests scored using 4 different methods 
of demographic correction (i.e., no correction, age correction, education correction, age 
and education correction). The following prototype model was built 4 different times 
(once for each of the norming methods) and then those models were compared using R2 
and AIC values:  CDR-SB scores =  
β1Memory and Learning + β2 Executive Function + β3 Language + β4 Attention   
 Four sets of regressions were used to examine:  
1. The relationship between CDR-SB and the “raw” (i.e., corrected for gender 
only) cognitive composite scores. 
2. The relationship between the CDR-SB and cognitive composite scores derived 
from age corrected test data.  
3. The relationship between the CDR-SB and cognitive composite scores derived 
from education corrected test data.  
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4. The relationship between the CDR-SB and cognitive composite scores derived 
from age and education corrected test data.  
There was one model for each norming method as specified above, so 
determining which model was “best” required comparing the merits of the various 
models. This represented a statistical conundrum, because the models were built using 
different data (data subject to different norming methods) and as such are “non-nested” 
models. In the context of least squares regression, nested models are easily testable for 
differences at a given significance level but there are no universally agreed upon methods 
for comparing non-nested models. In practice, various parameters such as a model’s R2 
value and AIC are typically used for model selection purposes in lieu of significance 
tests. For consideration, some authors have convincingly argued that null hypothesis 
testing itself is undesirable and gives a false sense of precision when none is warranted 
and as such, the lack of significance testing in this project is not viewed as a particular 
shortcoming (Harrel, 2001).  
 R2 values represent the total amount of variability in the criterion variable, in this 
study the CDR-SB, accounted for by the predictor variables, in this case the cognitive 
composite scores (Field, 2013). Thus, models with a higher R2 value are desirable and 
indicate that the predictor variables are capturing more variation in the criterion of 
interest than models with a lower R2 value. Cohen (1988) has set conventions for 
interpreting R2 values that are used widely in the social sciences, with R2 = .02 considered 
a small effect, R2 = .25 considered a medium effect, and R2 = .40 or greater considered to 
be a large effect. Thus, there would be clear and meaningful differences between the 
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models if the R2 values associated with the different models fell into different effect size 
categorizations. For example, if the R2 value in equation 2 was moderate (R2 > .25) and 
the R2 value in equation 1 was strong (R2 > .4), then model 1 is clearly superior to model 
2. Differences that are smaller in magnitude may suggest the superiority of one model 
versus another model, but there are no universally accepted criteria for determining the 
incremental difference required to make a clinically significant contribution to clinical 
practice. In the context of dementia evaluation, it can be argued that any increase in R2 
value that might lead to greater diagnostic accuracy is desirable and may be of practical 
significance at a population level.  
 AIC was developed by Hirotogu Akaike in 1974 (Akaike, 1974) and is typically 
employed in logistic regression but can also be computed for least squares regression. 
This parameter is used commonly for model selection and considers both a model’s 
overall fit and its parsimony. While AIC is often used to compare nested models, 
Akaike’s work makes no statement that models must be nested, and thus this statistic is 
often used to compare non-nested models. One calculates the lowest AIC value of all 
models being considered and then evaluates the change in AIC between different models 
(the delta AIC). According to Burnham and Anderson (2004), models having a delta AIC 
less than or equal to 2 have substantial support and are comparable to the model with the 
minimum AIC value. Those in which 4 ≤ delta AIC ≤ 7 can be said to have considerably 
less support, and those where delta AIC > 10 have essentially no support. Therefore, the 
models above can be compared semi-quantitatively using their AIC values with the 
model having the lowest AIC value being the most desirable.  
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Primary Study Hypothesis 
H1:  Age and education correction increase the extent to which NP tests are able to 
capture functional decline due to cognitive loss in dementia. This will be tested by 
comparing R2 and AIC values from regression equation 1 with regression equation 4.  
H01:  Age and education correction decrease or have no effect on the extent to which NP 
tests are able to capture functional decline due to cognitive loss in dementia.  
H2:  Age correction decreases the extent to which NP tests are able to capture functional 
decline due to cognitive loss in dementia. This will be tested by comparing R2 and AIC 
values from regression equation 1 with regression equation 2.    
H02:  Age correction increases or has no effect on the extent to which NP tests are able to 
capture functional decline due to cognitive loss in dementia. 
H3:  Education correction increases the extent to which NP tests are able to capture 
functional decline due to cognitive loss in dementia. This will be tested by comparing R2 
and AIC values from regression equation 1 with regression equation 3.  
H03:  Education correction decreases or has no effect on the extent to which NP tests are 
able to capture functional decline due to cognitive loss in dementia.  
Optimal demographic correction as determined by the analyses above may result in better 
diagnostic performance when differentiating normal controls from individuals with 
dementia. Comparison of the R2 and AIC values of the various regression equations 
presented above will clarify the extent to which various types of demographic correction 
influence the ability of cognitive tests to detect meaningful variation in dementia severity. 
While the above hypotheses are not associated with significance levels, R2 values and 
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AIC values are commonly used to compare non-nested models and allow the important 
research questions above to be answered quantitatively.  
Data Preparation 
The plan was to identify missing values and either exclude them on a case-wise 
basis during analyses or replace them with the group-wise mean value (i.e., a missing 
value for a patient with mild dementia would be replaced using the mean of that variable 
for individuals with mild dementia). The strategy used depended on the number of 
missing data points and other specific data characteristics that were not known prior to 
receiving the data set. Primary tests of study hypotheses may further benefit from 
exclusion of outliers and transformation of poorly behaved variables that deviate 
markedly from normality. It should be noted that linear regression does not explicitly 
require multivariate normality (Allison, 1999). As with most parametric models however, 
relative normality prior to model fitting may aid in model stability, generalization, and 
avoiding violations of other assumptions downstream (Tabachnick & Fidell, 2012).  
To assess normality, histograms and Q-Q plots were constructed for each of the 
cognitive tests for visual inspection (see appendix). Skew and kurtosis values were 
calculated. In general, skew and kurtosis values < 1 are considered acceptable, 
particularly given that multiple linear regression does not require normally distributed 
variables (George & Mallery, 2016). Parametric methods such as the Komolgorov-
Smirnoff test were not appropriate for the present study because with the large sample 
size, they would be overpowered and likely detect tiny departures from normality. 
Similarly, it was also inadvisable to perform statistical tests of skew and kurtosis values 
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by dividing them by their standard errors and then comparing them to a Z-score 
distribution (Field, 2013). Data transformations were considered and applied as needed 
with the caveat that model interpretability was a primary concern and thus variable 
transformation was avoided if at all possible, particularly for the CDR-SB. Univariate 
outliers were identified through the use of Boxplots, with values plus or minus 3 times 
the interquartile range of a variable screened as potential outliers (Field, 2013). 
Multivariate outliers were identified within the regression analyses through several 
different methods described below. 
Statistical Analytic Strategies 
Prior to modeling, the data was described by calculating descriptive statistics 
including the mean, standard deviation, and range of all study variables. The 
intercorrelations of the cognitive test scores, age, education, and the CDR-SB were 
calculated for each different norming method using bivariate Pearson correlations. These 
correlations provided a direct measure of the strength of relationship between a given 
cognitive test and the criterion measure of interest. These bivariate correlations aided in 
the interpretation of the hierarchical linear regression analyses for testing primary study 
hypotheses, helped to detect suppression, and served as a measure of variable importance 
(Nathans et al., 2012). Following descriptive statistics and analysis of intercorrelations 
between tests, the primary study hypotheses was tested using least squares hierarchical 
multiple linear regression. This analytic technique is appropriate when one wishes to 
examine the magnitude of association between a set of continuous predictor variables and 
a continuous outcome variable (Field, 2013).   
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The order of variable entry was defined a priori, which avoided the pitfalls 
inherent in methods such as stepwise regression and promoted better generalization as 
opposed to overfitting of sample data (Harrell, 2001). The cognitive composite scores 
were entered in the following order in a block wise fashion using an alpha of 0.5 to enter 
the model: memory, executive functioning, language, and attention. It was hypothesized 
that memory and executive function would be the most important predictors in the model 
irrespective of norming method followed by language, then attention. The models were 
evaluated based on R2 values and adjusted R2. Models were compared by examining R2 
differences between models and AIC differences. The importance of individual cognitive 
domains were evaluated by examining R2 change, standardized regression weights 
associated with each cognitive domain, and significance of terms in the final models. The 
model construction strategy allowed for a precise determination of the different 
proportions of variance accounted for by each cognitive domain and how the magnitude 
of those relationships was affected by demographic correction. 
Regression requires several assumptions: linearity of the relationship between 
predictor and criterion variables, absence of multicollinearity, absence of outliers 
amongst the independent and dependent variables, independence of errors, and 
homoscedasticity (Tabachnick & Fiddell, 2012). Linearity was examined visually using 
scatterplots and bivariate Pearson correlations described above. Multicollinearity was 
addressed a priori by design, through creating homogeneous cognitive composites that 
were relatively distinct from one another by virtue of their item content. Bivariate 
Pearson correlations between the test variables allowed for quantitative evaluation of any 
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multicollinearity between variables. In general, variables with correlations above 0.7 – 
0.8 should not be used together in a regression equation (Allison, 1999). Variance 
Inflation Factor (VIF) and tolerance values calculated as a result of the regressions 
complemented these a priori methods of detecting multicollinearity. In general, VIF 
above 10 and Tolerance values below 0.2 are considered as representing possible 
problems (Field, 2013). Outliers and influential data points were evaluated using 
regression diagnostics.  
In a multiple regression context, outliers can be defined as points that differ 
substantially from the main trend of the data (Field, 2013). Examination of standardized 
and studentized residuals following model fitting was used to identify such points which 
were further inspected for possible removal. Single data points with standardized 
residuals above or below 3.29 were considered for removal, as values this high are 
unlikely to occur based on chance (Field, 2013). The proportion of cases with 
standardized residuals greater or less than 1.96 was also examined, because 95% of data 
points should fall within these values in a well-fitting model. Multivariate outliers were 
also evaluated by calculating their distance from the group centroid via Mahalanobis 
distance, which is distributed as a Chi-square and can be evaluated at p < .001 to detect 
multivariate outliers (Meyers et al., 2016).  
Outlying data points may not be a large concern if they are not overly influential 
on the overall model. To assess influence, leverage values were examined. Leverage 
gauges the influence of the observed value of a case on a particular variable over the 
predicted values of a regression solution. The average expected leverage is defined as 
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(k+1/n) with cutoff values around 3 times the average leverage value typically considered 
as indicative of points with undue influence (Pituch & Stevens, 2015). This statistic was 
complemented by calculation of studentized deleted residuals, which represented the 
difference between the prediction of an observed value when it is and when it is not 
included in the model divided by its standard deviation (Field, 2013). Influence on the 
overall model was evaluated using Cook’s distance, with values greater than 1 potentially 
indicating cause for concern (Cook & Weisberg, 1982).  
Independence of errors or lack of autocorrelation amongst residuals was assessed 
using the Durbin-Watson statistic which tested for serial correlations between adjacent 
residuals. This statistic ranges from 0 to 4, with values greater than 2 implying negative 
correlation and below 2 implying positive correlation. Rule of thumb suggested by Field 
(2013) for evaluating this statistic are that values less than 1 or greater than 3 are 
indicative of a possible problem. Homoscedasticity was evaluated by plotting 
standardized residuals vs. standardized predicted values, which should ideally assume a 
random pattern. Funnel shaped plots may suggest heteroscedasticity and a curved 
appearance may indicate departures from normality (Field, 2013). Histograms of residual 
values and normal p-p plots were also calculated to examine normality of residuals.  
Power Analysis 
 Power for multiple regression includes tests of the overall model being 
significantly different than 0, tests of R2 increase at each step in variable entry, and tests 
for the significance of individual regression coefficients. G*Power 3.1.9.4 was used to 
examine power for each of these tests assuming a moderate effect size (f2 = 0.15) and α = 
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.05 at the desired power level of 0.8, as recommended by Cohen (1988) (Faul et al., 
2007). A total sample size of n = 85 was required to achieve power of 0.803 for tests of 
the R2 deviation from 0 and the same sample size was required for tests of R2 increase. A 
total sample of 55 was required for tests of model coefficients. 
Summary 
 The current investigation examined the impact of demographic correction on the 
diagnostic validity of cognitive tests in the service of differentiating between normal 
cognitive aging, MCI, and dementia. The proposed study challenges the standard practice 
of demographic correction thought to universally improve cognitive testing instruments’ 
sensitivity to impairment. The NACC appointed a specific task force to choose the set of 
measures that are freely available and have adequate discriminatory powers to encourage 
uniform data collection strategies and collaboration between researchers. The resulting 
data set, the UDS Version 3, was the focus of the current study because of its size and 
diversity. It contains healthy control participants as well as those meeting the diagnostic 
criteria for MCI and Alzheimer’s dementia. The results of this study may not only tip the 
debate towards an optimum scoring method to detect the earliest stages of degenerative 
cognitive impairment, but it may also advise the illusive search for a set of cognitive 
biomarkers that distinguish individuals who are experiencing the effects of normal aging 
from those in the process of developing a neurodegenerative disease. The earlier and more 
accurately we can diagnose Alzheimer’s, the greater chance we have of altering the 
disease trajectory, potentially improving the future for the many individuals that are yet to 
be diagnosed and other stakeholders.   
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Chapter 4: Results  
The purpose of the present study was to investigate the impact of demographic 
corrections on the diagnostic validity of cognitive tests when differentiating between 
normal cognitive aging and AD dementia. The standard practice of demographically 
correcting raw test scores for age and education is widely believed to universally improve 
the scores’ sensitivity to detecting cognitive impairment for all age groups but has been 
challenged by researchers who believe that uncorrected scores may be more sensitive for 
detecting impairment in the aging population (Hassenstab et al., 2016; Hessler et al., 
2014; Holtzer et al., 2008; O’Connell & Tuokko, 2010; Wyman-Chick et al., 2018) . 
Hierarchical multiple linear regression was used to predict the outcome variable, the 
CDR-SB scores, by a combination of cognitive composite scores derived from cognitive 
tests scored using 4 different methods of demographic correction.  
The cognitive domain composite scores for memory, executive function, 
language, and attention were the predictor variables. The composite construction strategy 
was based on the same theoretical grouping of tests used in the work of Weintraub et al. 
(2018a). This theoretically driven strategy is well grounded in established principles of 
NP function and localization. Weintraub and colleagues (2018b) developed a normative 
calculator for the UDS-NAB using test data of 3602 cognitively normal participants over 
the age of 60. This model was used to standardize the test scores and adjust for the 
various demographic corrections that were compared in the regression analysis. The 
composite score for the memory domain (MEMO) was composed of the scores from 2 
tests, Craft Story 21 and the Benson Complex Figure recall task. The executive function 
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domain (EXEC) was constructed from verbal fluency F & L and TMT B tests. The 
language domain (LANG) was derived from the MINT and Animal Fluency measures. 
And the attention domain composite score (ATTN) was composed of DGF and DGB 
tests. For a full discussion of the reliability and validity of each individual NP test, see 
chapter 3. Cognitive composites offer a more complete sampling of cognitive abilities 
than a single cognitive test by virtue of broader item content and are advantageous 
statistically as they can be more sensitive to cognitive changes in preclinical dementia 
therefore more reliable than the single measures from which they were derived. These 4 
domains were chosen because models with fewer explanatory variables are more 
desirable than complex models due to enhanced interpretability (James et al., 2017). For 
more details on how each of the demographic scores were computed see the full 
discussion in chapter 3 under the subheadings “Cognitive Test Scoring” and “Creation of 
Cognitive Composites”.   
The order of entry into hierarchical regression models was defined a priori. 
Memory measures have been shown to be the earliest indicators of decline in AD even in 
minimally symptomatic individuals, and executive function impairment usually follows 
(Karantzoulis & Galvin, 2011). Deficits in language functioning, including semantic 
verbal fluency and visual object confrontation are also characteristic of AD (Salmon & 
Bondi, 2009). Individuals with AD may also exhibit impairment with attention and 
working memory though these abilities may be well preserved until later into the illness 
(Cherry et al., 2002). The following prototype model was built 4 different times, once for 
each norming method: 
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CDR-SB scores = β1MEMO + β2 EXEC + β3 LANG + β4 ATTN  
The first model was corrected for gender only (G) and considered the raw scores for the 
purpose of the analysis. The second model was age corrected only (GA). The third model 
was education corrected only (GE). The fourth model was corrected with a combination 
of both age and education (GEA). Therefore, the abbreviated combination of MEMO_G, 
is the score for the memory composite score corrected only for gender (raw score), while 
MEMO_GEA is the memory composite score corrected for gender, education, and age.   
Four sets of regressions will be used to examine:  
1. The relationship between CDR-SB and the G cognitive composite scores. 
2. The relationship between the CDR-SB and GA cognitive composite scores.  
3. The relationship between the CDR-SB and GE cognitive composite scores.  
4. The relationship between the CDR-SB and GEA cognitive composite scores.  
Models were compared by examining R2 differences between the models and AIC 
values. This strategy clarified the extent to which the raw scores and various 
demographic corrections influenced the ability of the cognitive tests to detect meaningful 
variation in functional changes due to cognitive loss from AD dementia. The importance 
of individual cognitive domains was evaluated by examining R2 change, standardized 
regression weights associated with each cognitive domain, and significance of terms in 
the final models. It also allowed for the precise determination of the different proportions 
of variance accounted for by each cognitive domain with each norming method. 
Determining which model was “best” required comparing the merits of the various 
models because there was one model for each norming method as specified above. 
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The overarching research question was how demographic corrections affected the 
strength of the relationship between cognitive test scores and CDR-SB. The primary 
study hypothesis was that age and education correction would increase the extent to 
which NP test scores were able to capture functional decline due to cognitive loss in 
dementia. There were also 2 subhypotheses 1) age correction alone would decrease the 
extent to which NP tests were able to capture functional decline due to cognitive loss in 
dementia, and 2) education correction alone would increase the extent to which NP tests 
were able to capture functional decline due to cognitive loss.  
Chapter 4 opens with data collection and participant selection information that 
includes a review of the inclusion and exclusion parameters that determined the final 
sample size. Descriptive and demographic characteristics of the final sample extracted 
from the entire data set provided by NACC. A discussion of the statistical assumptions 
necessary for the analyses, and a complete report of the findings organized by the 
research questions, including tables that best illustrated the results of the analyses and 
effect sizes. The chapter closes with a precise summary of hypotheses testing.  
Data Collection 
The data set was obtained from the University of Washington’s NACC by 
submitting the abstract from the present study and signing a data use agreement. To date, 
the NACC coordinated the collection of longitudinal data on 967 different variables for 
more than 100,000 participants. This study was limited to only data gathered on the most 
recent version of the UDS-3 implemented in March 2015 because it reflected changes in 
how dementia syndromes are classified in current clinical practice with an updated 
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version of the UDS-3 NAB that allowed researchers to collaborate using freely-available 
standardized testing instruments. For a complete discussion on how each ADC enrolls 
subjects and gathers data, see chapter 3 “The National Alzheimer’s Coordinating Center 
Uniform Data Set 3”. NACC subjects are best described as a referral-based or volunteer 
case series and thus are not a statistically representative sample of the population. The 
complete UDS-3 NAB data included a robust group of individuals with normal cognition 
as well as those with various etiologies of neurodegenerative diseases. The primary goal 
of this study was to inform the use of NP tests to differentiate between normal cognitive 
aging and dementia in the most commonly encountered situations, so the subjects were 
filtered to include only a primary etiologic diagnosis of AD in people 60 years and older 
with a CDR-SB score < 9.5. This cutoff excluded individuals with moderate to severe 
dementia for reasons fully justified in chapter 3 under “Participant Selection and 
Stratification”.  
Sample Descriptives 
The case processing summary showed no missing data. From the more than 
100,000 participants in the full data set, 8724 subjects met all inclusion and exclusion 
criteria (n = 8724), 5192 females and 3532 males. They ranged in age from 60 to 101 
with an average age of 74. The majority earned a bachelor’s degree with a range of 
formal education from 9 years to 21 years. Table 1 contains the descriptive statistics for 
all study variables. The frequencies tables were visually inspected for anomalies, these 
values all fell within expected ranges.. Table 2 used the outcome measure, to classify the 
subjects according to their CDR-SB scores into categories of Normal Cognition, MCI, or 
97 
 
Demented. The majority of subjects, 6237, fell into the normal cognition range, 1505 had 
a diagnosis of MCI, and 982 subjects met the criteria for dementia.  
 
Table 1 
Descriptive Statistics for All Variables  
 
Variable Mean SD Min Max Range IQR Skew Kurtosis 
AGE 74.12 7.87 60 101 41 12  .32 - .46 
SEX   .60   .49 0 1 1 1 -.39      -1.85 
EDU 16.24 2.51 9 21 12 4 -.32    .20 
CDR-SB  .83 1.68 0 9 9 .50 2.53  6.30 
MEMO_GEA -.4595 1.13 -3.83 2.78 6.62 1.47 -.56  -.34 
MEMO_GA -.4635 1.14 -3.69 2.52 6.21 1.48 -.59 -.20 
MEMO_GE -.4592 1.16 -3.56 2.69 6.25 1.51 -.53 -.25 
MEMO_G -.4632 1.17 -3.37 2.43 5.80 1.52 -.52 -.29 
EXEC_GEA -.3411 1.08 -4.59 2.48 7.07 1.12 -1.07 1.36 
EXEC_GA -.3482 1.12 -4.40 2.46 6.86 1.20 -1.07 1.24 
EXEC_GE -.3408 1.11 -4.45 2.59 7.04 1.17 -1.06 1.22 
EXEC_G -.3479 1.15 -4.28 2.56 6.83 1.23 -1.06 1.10 
LANG_GEA -.3459 1.14 -9.09 2.95 12.04 1.24 -1.70 6.16 
LANG_GA -.3528 1.17 -8.91 3.03 11.94 1.29 -1.58 5.36 
LANG_GE -.3457 1.17 -8.88 3.00 11.88 1.27 -1.63 5.66 
LANG_G -.3525 1.20 -8.80 3.01 11.80 1.33 -1.51 4.94 
ATTN_GEA -.1234   .88 -3.32 2.93 6.26 1.18 .27 .05 
ATTN_GA -.1282   .90 -3.39 3.01 6.40 1.20 .28 .05 
ATTN_GE -.1233   .89 -3.41 3.01 6.42 1.20 .28 .04 
ATTN_G -.1280   .91 -3.52 2.83 6.35 1.16 .30 .04 
Note. n = 8724. n = 5192 females. n = 3532 males. Memory composite score (MEMO). 
Executive function composite score (EXEC). Language composite score (LANG). 
Attention composite score (ATTN). Scores corrected for gender, education, and age 
(GEA). Scores corrected for gender, and age (GA). Scores corrected for gender, and 














A preliminary regression analyses was run to look for outliers identified using 
standardized and studentized residuals following model fitting. Single data points with 
residuals above or below 3.29 were considered for removal as they were unlikely to occur 
by chance (Field, 2013). The proportion of cases with standardized residuals greater or 
less than 1.96 were also examined because it was desired that 95% of data points fell 
within these values for a well-fitting model. Distances were calculated using 
Mahalanobis, Cook’s, and Leverage values. Using a Chi-square table P = .001 and 4df, 
Descriptive Statistics Grouped by Dementia Severity Level 
 Normal 
N = 6237 
MCI 
N = 1505 
Demented 
N = 982 
 





SD Range Mean 
 
SD Range Mean 
 
SD Range 
CDR-SB  .10 .30    2.0 1.23 .90 5.12 4.90 1.70 6.50 
MEMO_GEA -.00 .78 5.98 -1.15 .94 5.12 -2.31  .81 4.69 
MEMO_GA -.00 .79 5.85 -1.15 .94 5.12 -2.34  .81 4.28 
MEMO_GE -.01 .81 5.71 -1.18 .94 5.32 -2.36  .80 4.23 
MEMO_G -.02 .82 5.59 -1.19 .95 5.00 -2.39  .80 5.80 
EXEC_GEA -.32 .80 6.32   -.71 1.06 6.72 -1.74 1.35 5.92 
EXEC_GA  .01 .88 5.89  -.72 1.10 6.24 -1.80 1.36 6.40 
EXEC_GE -.01 .83 6.35  -.74 1.08 6.44 -1.80 1.36 6.34 
EXEC_G -.01 .87 6.71  -.76 1.15 5.99 -1.85 1.36 6.83 
LANG_GEA -.00 .80 7.93  -.84 1.07 10.80 -1.79 1.59 10.56 
LANG _GA  .00 .84 8.35  -.85 1.08 11.01 -1.84 1.58 10.13 
LANG _GE  .01 .82 8.37  -.87 1.09 10.63 -1.83 1.60 10.37 
LANG _G  .02 .86 8.72  -.88 1.10 10.84 -1.88 1.59 11.80 
ATTN_GEA  .01 .86 5.64  -.32  .82 5.83  -.65 .84 5.92 
ATTN _GA  .01 .88 5.89  -.33  .83 5.83  -.69  .84 6.04 
ATTN _GE  .02 .87 5.68  -.34  .82 5.90  -.68  .83 5.97 
ATTN _G  .02 .89 5.66  -.35  .83 5.89  -.72  .83 6.35 




the cutoff was 18.47. Cook’s distance values over .00045877 could have been considered 
outliers and leverage values over .00114626 could also been considered for removal. No 
data violated all three markers and the data set was kept in its entirety without fear that 
outliers biased results because of the large size of the data set. Tests to see if the data met 
the assumption of collinearity indicated that it was not a concern. VIF and Tolerance 
values were examined because VIF > 10 and Tolerance < .02 could be problematic, none 
of the values violated those boundaries. The data also met the assumption of independent 
errors, Durbin Watson values that were all close to 2 and are included in Table 7.  
Histograms and Q – Q plots were visually inspected (see Appendix). The 
histograms confirmed normality of the variables. All test score variables were roughly 
centered over 0 and the majority of the scores fell between – 2 and 2. Skew and kurtosis 
values are included in Table 1, values < 1 are generally considered acceptable but 
multiple linear regression does not require normally distributed variables (George & 
Mallery, 2016). The slight negative skew for the test variables was expected as 
individuals with impaired performance perform below normal. Q – Q plots were 
inspected for linearity and observed values adhered well to the line of best fit (expected 
values), they were not completely on the line, but close, so there were no obvious 
violations of this assumption. The departure from normality appeared more significant as 
the values of the CDR-SB increased (a higher dementia severity) which followed logic 
that the CDR-SB is more accurate at predicting normal cognition and less accurate at 
predicting demented people (see Appendix A). Homogeneity and homoscedasticity were 
examined using boxplots. The length of the boxes and their “whiskers” had 
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approximately the same spread so there were no obvious violations of this assumption. 
The data also met the assumption of non-zero variances as all values were greater than 0. 
Pearson correlations also showed no violations of collinearity between the outcome 
measure, the CDR-SB, as all values were less than .7. Table 3 contains the correlations 
for GEA model; Table 4 shows the GA model correlations; Table 5 shows the 
correlations for the GE model, and; Table 6 shows the correlations for the G (raw) model. 
The correlations have a negative relationship as expected. The lower the test scores, the 
higher the CDR-SB score, in other words people performed worse on the tests as their 
dementia severity increased.  
Table 3 
Pearson Correlations for Gender, Age, and Education Corrected Scores 
 
 
 CDRSUM MEMO_GEA EXEC_GEA ATTN_GEA LANG_GEA 
CDRSUM  1 -.645** -.507** -.240** -.512** 
MEMO_GEA  -.645** 1 .483** .287** .559** 
EXEC_GEA  -.507** .483** 1 .463** .564** 
ATTENT_GEA  -.240** .287** .463** 1 .305** 
LANG_GEA  -.512** .559** .564** .305** 1 




Pearson Correlations for Gender and Age Corrected Scores 
 
 CDRSUM MEMO_GA EXEC_GA ATTN_GA LANG_GA 
CDRSUM  1 -.645** -.505** -.248** -.513** 
MEMO_GA  -.646** 1 .501** .309** .574** 
EXEC_GA  -.505** .501** 1 .490** .589** 
ATTENT_GA  -.248** .309** .490** 1 .335** 
LANG_GA  -.513** .574** .589** .335** 1 





Pearson Correlations for Gender and Education Corrected Scores 
 
 CDRSUM MEMO_GE EXEC_GE ATTN_GE LANG_GE 
CDRSUM  1 -.651** -.517** -.255** -.519** 
MEMO_GE  -.651** 1 .511** .308** .582** 
EXEC_GE  -.517** .511** 1 .477** .588** 
ATTENT_GE  -.255** .308** .477** 1 .325** 
LANG_GE  -.519** .582** .588** .325** 1 





Pearson Correlations for Raw Scores 
 
 CDRSUM MEMO_G EXEC_G ATTN_G LANG_G 
CDRSUM  1 -.651** -.515** -.263** -.520** 
MEMO_G  -.651** 1 .528** .329** .595** 
EXEC_G  -.515** .528** 1 .503** .611** 
ATTENT_G  -.263** .329** .503** 1 .354** 
LANG_G  -.520** .595** .611** .354** 1 
Note. N = 8724. ** p < .001 (2-tailed). 
 
 
The bivariate correlations also supported the order of entry into the hierarchical 
regression equation for the testing the main hypotheses; memory composite scores 
showed the strongest relationship to the CDR-SB (α = -.65, p < .001) so entering memory 
scores into the model first was supported; executive function and language composite 
scores both demonstrated moderate relationships with the CDR-SB (α = -.51, p < .001) so 
they were entered second and third respectively, and; the attention composite scores 
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showed a weak yet still statistically significant relationship (α = .25, p < .001) to the CDR 
– SB so entering these scores into the regression equation last was also supported.  
Regressions to Predict Dementia Severity Rating by Norming Method 
Hierarchical multiple regression was conducted to predict CDR-SB, a clinical 
measure of functional changes due to cognitive loss, from the memory, executive 
function, language, and attention test composite scores that were normed by 4 different 
methods. R2 and AIC values were compared to analyze the extent to which the raw scores 
and demographically corrected scores influenced the ability of the tests to capture 
meaningful variation in the CDR-SB. See Table 7 for an overall summary of the 
significance of each of the models by norming method. The individual predictor variable 
results for each norming method are reported in Table 8.  
The first hierarchical multiple regression was conducted to predict CDR-SB 
scores from memory scores, executive function scores, language scores, and attention 
scores adjusted for gender, age, and education. Model 1 showed memory test scores 
accounted for 41.6% of the CDR-SB variability, R2 = .416, F(1, 8722) = 6213.10, p < 
.001. Model 2 showed executive function scores accounted for an additional 5% of the 
variability in the CDR-SB, F(1, 8721) = 809.94, p < .001, R2 = .05. Model 3 showed 
that language had a smaller yet still significant effect by accounting for 1% of the 
variability in the CDR-SB, F(1, 8720) = 169.06, p < .001, R2 = .01. Model 4 showed 
that attention scores were again significant even though they only captured .1% of the 
variance in the CDR-SB, F(1, 8719) = 19.69, p < .001, R2 = .001. The complete model 
captured 47.7% of the variability in the CDR-SB, R2 = .477, p < .001. 
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Further analysis demonstrated the significance of each predictor. Memory 
accounted for 42% of the CDR-SB score,  = -.65, t(8722) = -78.82, p < .001, pr2 = .42. 
In other words, for every one unit decrease in memory scores there was an increase in 
dementia severity rating by .65 SD. In the second model executive function accounted for 
an additional 9% of the CDR-SB when controlling for memory,  = -.25, t(8721) = -
28.46, p < .001, pr2 = .09. In the third model language accounted for another 2% of the 
CDR-SB score over and above memory and executive function scores,  = -.13, t(8720) = 
-13, p < .001, pr2 = .02. And in the fourth model attention was again a significant 
predictor, but only accounted for .22% of the CDR-SB score,  = .04, t(8719) = 4.44, p < 
.001, pr2 = .0022. 
A second hierarchical multiple regression was conducted to predict CDR-SB 
scores from memory test scores, executive function test scores, language test scores, and 
attention test scores that were adjusted for gender and age. Memory test scores accounted 
for 41.7% of the CDR-SB variability, F(1, 8722) = 6235.38, p < .001, R2 = .417. Model 2 
showed executive function scores accounted for an additional 4% of the variability in the 
CDR-SB, F(1, 8721) = 809.94, p < .001, R2 = .04. Model 3 showed that language had 
a smaller yet still significant effect by accounting for .09% of the variability in the CDR-
SB, F(1, 8720) = 145.83, p < .001, R2 = .009. Model 4 showed that attention scores 
were again significant even though they only captured .2% of the variance in the CDR-
SB, F(1, 8719) = 27.08, p < .001, R2 = .002. The total model accounted for 47.1% of 
the variability in the CDR-SB score, R2 = .471, p < .001. 
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The significance of the predictors for this model showed memory to have the 
same value as in the model corrected for gender, education, and age,  = -.65, t(8722) = -
78.96, p < .001, pr2 = .42. Executive function accounted for another 8% of the CDR-SB 
score when holding memory constant,  = -.24, t(8721) = -26.62, p < .001, pr2 = .08. 
Language picked up another 2% of the CDR-SB score when controlling for memory and 
executive function scores,  = -.13, t(8720) = -12.08, p < .001, pr2 = .02. Attention, 
although statistically significant, only accounted for an additional .31% of the CDR-SB 
score over and above the memory, executive function, and language scores,  = .05, 
t(8719) = 5.20, p < .001, pr2 = .0031. 
The third hierarchical multiple regression was conducted to predict CDR-SB 
scores from memory test scores, executive function test scores, language test scores, and 
attention test scores that were adjusted for gender and education. Memory test scores 
accounted for 42.3% of the CDR-SB variability, F(1, 8722) = 6401.38, p < .001, R2 = 
.423. Executive function scores accounted for an additional 4.6% of the variability in the 
CDR-SB, F(1, 8721) = 755.64, p < .001, R2 = .046. Language had a smaller yet still 
significant effect by accounting for .8% of the variability in the CDR-SB, F(1, 8720) = 
139.86, p < .001, R2 = .008. Lastly, attention scores were again significant even though 
they only captured .1% of the variance in the CDR-SB, F(1, 8719) = 16.18, p < .001, 
R2 = .001. The total model accounted for 47.9% of the variability in the CDR-SB 
scores, R2 = .479, p < .001. 
The significance for each predictor adjusted for gender and education showed 
memory again accounting for 42% of the CDR-SB score,  = -.65, t(8722) = -80.01, p < 
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.001, pr2 = .42. Executive function accounted for an additional 8% of the CDR-SB score 
over and above memory,  = -.25, t(8721) = -27.49, p < .001, pr2 = .08. Language picked 
up an addition 2% of the CDR-SB score,  = -.12, t(8720) = -11.83, p < .001, pr2 =.02. 
Attention was again significant while accounting for .18% of the CDR-SB score,  = .04, 
t(8719) = 4.02, p < .001, pr2 = .0018. 
The fourth hierarchical multiple regression was conducted to predict CDR-SB 
scores from raw scores, adjusted for gender only (raw scores). Memory test scores again 
accounted for 42% of the CDR-SB variability, F(1, 8722) = 6420.78, p < .001, R2 = .424. 
Executive function scores accounted for an additional 4.1% of the variability in the CDR-
SB scores, F(1, 8721) = 662.44, p < .001, R2 = .041. Language had a smaller yet still 
significant effect by accounting for .07% of the variability in the CDR-SB, F(1, 8720) = 
120.73, p < .001, R2 = .007. Lastly, model 4 showed that attention scores were again 
significant even though they only captured .1% of the variance in the CDR-SB, F(1, 
8719) = 22.70, p < .001, R2 = .001. The complete model accounted for 47.3% of the 
variability in the CDR-SB scores.R2 = .473, p < .001. 
The significance of the predictors for the raw scores showed memory again at 
42%,  = -.65, t(8722) = -80.13, p < .001, pr2 = .42. Executive function accounted for an 
additional 7% of CDR-SB scores,  = -.24, t(8721) = -25.74, p < .001, pr2 = .07. 
Language accounted for 1% of the CDR-SB score,  = -.12, t(8720) = -10.99, p < .001, 
pr2 =.01. And attention was again statistically significant while only accounting for .26% 
of the CDR-SB scores,  = .04, t(8719) = 4.77, p < .001, pr2 = .0026. 
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The gender and education normed model captured the greatest amount of variance 
in the CDR-SB with 47.9% . The gender, education, and age normed model accounted for 
47.7% of the variance in the CDR-SB. The raw scores accounted for 47.3% of the 
variance and the model normed for gender and age captured the least amount of variance 
47.1% from the CDR-SB. The differences were small and did not fall into different effect 
size categorizations, but an argument can be made that any increase is of significant 
clinical value in dementia diagnostic evaluations. Each predictor was significant in every 
step of every regression for every norming method. Meaning no matter how the test 
scores were normed they all had important relationships with the CDR-SB. As expected, 
memory, executive functions, and language test scores significantly predicted the 
dementia severity rating in a negative direction, as test scores decreased, the dementia 
severity increased. However, an unexpected finding surfaced with the attention scores, 
while statistically significant, the contribution to the predicted outcome measure was 
much smaller than expected. The best explanation for the small effect size of the attention 
domain is that the ability to maintain attention is often well preserved until the later 
stages of AD. The majority of the sample group had normal cognition with inclusion 
criteria removing participants with a CDR-SB score above 9.5, meaning that individuals 
with moderate and severe dementia were excluded from this analysis. This decreased the 
lower end scores in the attention composite.  
Age-adjusted scores weakened the ability of the model to capture the variance in 
the CDR-SB, and the theory that raw scores are superior to other norming methods could 
not be supported when using a NP battery approach (Hassenstab et al, 2016; Hessler et 
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al., 2014; Holtzer et al.,2008; O’Connell & Tuokko, 2010; Wyman-Chick et al., 2018). 
The findings clearly suggested that correction for education is best practice for processing 
NP test scores in an older population because the 2 models that included education 
correction were superior to the models that did not included education correction. The 
model that was only corrected for education, leaving age correction out completely, 




Model Summary of Regressions for Prediction of CDR-SB Scores  













1MEMO_GEA .416 .416 1, 8722 6213.101 .416  
2 EXEC_GEA .466 .050 1, 8721   809.944 .466  
3 LANG_GEA .476 .010 1, 8720   169.055 .476  
4 ATTN_GEA .477 .001 1, 8719     19.692 .477 1.99 
        
Model 2 
 
1 MEMO_GA .417 .417 1, 8722 6235.376 .417  
2 EXEC_GA .461 .044 1, 8721   708.728 .461  
3 LANG_GA .470 .009 1, 8720   145.833 .470  
4 ATTN_GA .471 .002 1, 8719    27.080 .471 1.98 
        
Model 3 
 
1 MEMO_GE .423 .423 1, 8722 6401.380 .423  
2 EXEC_GE .469 .046 1, 8721   755.641 .469  
3 LANG_GE .478 .008 1, 8720   139.859 .478  
4 ATTN_GE .479 .001 1, 8719    16.182 .479 1.98 
        
Model 4 
 
1 MEMO_G .424 .424 1, 8722 6420.780 .424  
2 EXEC_G .465 .041 1, 8721   662.440 .465  
3 LANG_G .472 .007 1, 8720    120.733 .472  
4 ATTN_G .473 .001 1, 8719      22.703 .473 1.98 
Note. n = 8724. All p values were statistically significant p < .001. Memory composite score (MEMO). 
Executive function composite score (EXEC). Language composite score (LANG). Attention composite 
score (ATTN). Scores corrected for gender, education, and age (GEA). Scores corrected for gender, and 






Significance of Predictors by Norming Method 
Note: n = 8724. *p < .001. Memory composite score (MEMO). Executive function composite score (EXEC). Language composite score (LANG). Attention 
composite score (ATTN). Scores corrected for gender, education, and age (GEA). Scores corrected for gender, and age (GA). Scores corrected for gender, and 
education (GE). Raw scores (G) corrected for gender only.  
 Model 1 Model 2 Model 3 Model 4 
Predictors B SE B β B SE B β B SE B β B SE(B) β 
MEMO_GEA  -.96  .01  -.65* -.78  .01 -.52*    -.70  .01 -.47* -.71  .01 -.46* 
EXEC_GEA     -.40  .01  -.25*     -.32  .02  .20*  -.34  .02  -.22* 
LΑΝG_GEA       -.20 .02  -.13*  -.20  .02  -.13* 
ATTN_GEA          .07  .02 .04* 
MEMO_GA -.95 .01 -.65* -.77 .01 -.52* -.70 .01 -.48* -.70 .01 -.48* 
EXEC_GA    -.36 .01 -.24* -.29 .02 -.19* -.32 .02 -.21* 
LANG_GA       -.18 .02 -.13* -.19 .02 -.13* 
ATTN_GA          .09 .02 .05* 
MEMO_GE -.94 .01 -.65* -.76 .01 -.52* -.69 .01 -.48* -.70 .01 .49* 
EXEC_GE    -.38 .01 -.25* -.30 .02 -.20* -.33 .02 -.22* 
LANG_GE       -.18 .02 -.12* -.18 .02 -.13* 
ATTN_GE          .07 .02 .04* 
MEMO_G -.93 .01 -.65* -.75 .01 -.53* -.69 .01 -.48* -.69 .01 -.48* 
EXEC_G    -.35 .01 -.24* -.28 .02 -.19* -.30 .02 -.21* 
LANG_G       -.17 .02 -.12* -.17 .02 -.12* 
















GEA 41.6% 5.0% 1% .1% 47.7% 
GA 41.7% 4.4% .9% .2% 47.1% 
GE 42.3% 4.6% .8% .1% 47.9% 
G 42.4% 4.1% .7% .1% 47.3% 
Note: n = 8724. Scores corrected for gender, education, and age (GEA). Scores corrected for 
gender, and age (GA). Scores corrected for gender, and education (GE). Raw scores (G) 
corrected for gender only. 
 
The models were also compared using AIC values by computing the delta AIC 
values as seen in Table 9. The lowest AIC value was the model corrected for gender and 
education, which when subtracted from the other AIC values provided the model delta 
value. The best model had the lowest AIC value unless another model had a lesser delta 
AIC (Burnham & Anderson, 2004). Burnham and Anderson (2004) determined that 
models with delta AIC  2 have substantial support and are comparable to the model with 
the lowest AIC value. Models with delta AIC  4 to 7 have considerably less support and 
those with delta AIC > 10 have essentially no support. This is the same story told by R2 
only clearer. Age correction of cognitive tests created an inferior model. The best model 
was gender and education corrected model with all the other models having essentially no 












Delta AIC Value 
GEA 3373.47782  24.24 
GA   3469.066734 122.83 
GE   3346.239576 ** 
G   3433.620439   87.38 
Note: n = 8724. *p < .001. Scores corrected for gender, education, and age 
(GEA). Scores corrected for gender, and age (GA). Scores corrected for 
gender, and education (GE). Raw scores (G) corrected for gender only.  
 
 
Results of Main Hypotheses Testing 
The first hypothesis was that age and education correction would increase the 
extent to which NP test scores would capture functional decline due to cognitive loss in 
dementia. This hypothesis was supported. A comparison of the gender, education, and 
age corrected model to the raw score model showed the gender, age, and education model 
captured more variance, R2 = .477 than the raw scores, R2 = .473 so the null hypothesis 
was rejected. 
Subhypothesis 2 was that age correction would decrease the extent to which NP 
tests were able to capture functional decline due to cognitive loss in dementia. This 
hypothesis was also supported. A comparison of the gender and age corrected model to 
the raw score model showed the gender and age corrected scores, R2 = .471 captured less 
variance than the raw scores, R2 = .473 so the null hypothesis was rejected. 
Subhypothesis 3 was that education correction would increase the extent to which 
NP tests was able to capture functional decline due to cognitive loss in dementia. The 
comparison between the gender and education scored model, R2 = .479, showed that it 
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captured more variance in the CDR-SB than any other model so the null hypothesis was 
rejected. In short, the results of this hierarchical multiple regression showed that gender 
and education correction of test scores captured 47.9% of variance in CDR-SB, giving it 
a slight edge over the gender, education, and age corrected model which captured 47.7% 
of the variance in the CDR-SB. This was confirmed by the comparison of the AICs for 
the models (See Table 10). The best model was the one with the lowest AIC value, the 
model corrected for gender and education, and all the other models had essentially no 
support.  
Summary 
The overarching research question examined the effects of different types of 
demographic correction on the relationship between cognitive test scores and functional 
deterioration due to cognitive impairment as measured by the CDR-SB, a dementia 
severity measure. The first hypothesis, that age and education correction increased the 
extent to which NP test scores captured functional decline due to cognitive loss in 
dementia was supported. The first subhypotheses that age correction decreased the extent 
to which NP tests captured functional decline due to cognitive loss in dementia was also 
supported. The second subhypotheses, that education correction increased the extent to 
which NP tests captured functional decline due to cognitive loss in dementia was strongly 
supported. A comparison of the models showed that the education correction model 
captured the most variance, R2 = .479, in the CDR-SB score. The results of this 
hierarchical multiple regression showed that education correction of test scores made for 
a superior model by accounting for 47.9% of variance in CDR-SB. The comparison of the 
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AIC values for each model confirmed these findings. The gender and education corrected 
scores provided the best model with the other models having essentially no support. Age 
correction alone of NP tests in an older population created an inferior model. The 
differences between the models corrected for education alone and the education and age 
correction model were small, and an argument can be made that any increase is of 
significant clinical value. However, the necessary amount of increase or increment that 
would make a significant clinical difference on a population level was beyond the scope 
of this research. Chapter 5 addresses further interpretation of these findings, as well as 




Chapter 5: Discussion, Conclusions, and Recommendations 
The purpose of this study was to identify optimal normative methods for detecting 
pathologic cognitive changes in elderly individuals when using cognitive testing. 
Archival data from the NACC provided a large data set on which to perform a 
hierarchical multiple regression analyses to determine the strength of the relationships 
between cognitive test scores, normed 4 different ways, and the clinical dementia severity 
rating as measured by the CDR-SB. Total R2 values and AIC values were compared to 
determine which norming method captured the greatest amount of variance, in other 
words which of the models garnered the most support. The results of the analysis 
revealed the differences between the models were small and did not fall into different 
effect size categories, but a clear hierarchy was established with education-corrected 
scores demonstrating superiority over the other demographic correction methods. Age 
correction weakened the models’ ability to capture variance in the CDR-SB.  
The main hypothesis was that age and education correction would increase the 
extent to which NP test scores captured functional decline due to cognitive loss in 
dementia. This hypothesis was supported. A comparison of the gender, education, and 
age scored model to the model composed of raw scores showed the demographically 
corrected model captured more variance, R2 = .477 than the raw scores, R2 = .473. The 
first subhypothesis was that age correction would decrease the extent to which NP tests 
captured functional decline due to cognitive loss in dementia. This hypothesis was also 
supported because the comparison between the gender and age corrected model and the 
model composed of raw scores showed gender and age corrected scores, R2 = .471 
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captured less variance than the raw scores, R2 = .473. The second subhypothesis was that 
education correction would increase the extent to which NP tests captured functional 
decline due to cognitive loss in dementia. Support was provided for this hypothesis as the 
gender and age corrected model, R2 = .479, captured the most variance in the CDR-SB 
when compared to all other models. Age correction subtracted from the model’s ability to 
capture variance. While the differences were small, they suggested the superiority of the 
gender and education corrected model over all others. The major limitation to these 
results is that further work is necessary to determine the extent of the difference in R2 
value that is required to make this clinically significant on a population level as no 
universally accepted criteria exists. Had the models fallen into different effect size 
categories the interpretation of the results would have been clearer. All the models had 
large effect sizes, R2 values >.40 as per the conventions established by Cohen (1988). It 
can be argued that any increases in R2 value is desirable because it may lead to greater 
diagnostic accuracy when evaluating for dementia. The current study confirmed that age-
corrected scores are the least desirable method of norming in an older population. The 
findings of the current study also refute the idea that raw scores are superior to 
demographically corrected scores in NP testing when used in the service of dementia 
diagnostic evaluations that utilize a NP battery approach.  
Interpretation of the Findings 
 The purpose of norming cognitive tests in the elderly is to provide a point of 
comparison for detecting deviant performance that would be indicative of a 
neurodegenerative disease such as AD. The findings of the current study provided a clear 
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hierarchy between the models; the education-corrected scores generated a superior model 
that captured 48% of the variance in the CDR-SB while the age-corrected model 
produced an inferior model that captured 47% of the variability in the CDR-SB. A 
comparison of the AIC values confirmed that gender and education corrected scores 
constructed the superior model. The next step would logically be to determine what 
useful clinical significance a 1% increase in R2 translates into at a population level, but 
that is beyond the scope of the current study.  
 Sliwinisky et al., (1996) introduced the idea that conventional norms were not 
optimal for detecting deviant performance on cognitive tests because the norms contained 
individuals who were already in cognitive decline yet still performed within normal limits 
on testing. Their seminal work demonstrated that conventional norms; underestimated 
normal performance in the elderly; overestimated the variance in test scores; exaggerated 
cognitive decline due to normal aging, especially in the very old, and; produced norms 
that were less sensitive to detecting dementia making it more challenging to diagnose. 
Sliwinski et al. argued that correcting for age and education decreased the discriminative 
validity of their single memory test, and that the uncorrected raw scores were superior for 
detecting dementia. The present study challenged their findings by using different 
methods of norming to analyze the strength of test scores’ relationships with the gold 
standard for clinical dementia severity ratings. The results of the current study partially 
supported their work, correcting for age and education did produce an inferior model if 
looking only at memory scores. Raw memory scores indeed captured more variation in 
the CDR-SB. However, when a battery approach was utilized and executive processes, 
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language, and attention scores were taken into consideration, the raw scores did not 
capture as much variation as models that included correction for education. It was clear 
that when using a typical NP battery approach, adding education correction produced a 
better model. Because a diagnosis between normal cognitive aging and dementia is never 
determined by a single cut off score in clinical practice, correcting for education is an 
essential component when processing scores.  
In 2010 O’Connell and Tuokko expanded on Sliwinski et al.’s key idea that 
demographic corrections of cognitive test scores may not universally improve dementia 
classification accuracy. Their study concluded equivalent overall classification accuracy 
of demographically corrected scores and uncorrected test scores but the authors realized 
that their findings were of more importance when only one test was used, as in a 
dementia-screening evaluation, and of less clinical importance with a typical NP battery 
approach. O’Connell and Tuokko conceded numerous limitations in their data given its 
novel simulation methodology that necessitated replication to be of any clinical value. 
Although their conclusion was overall equivalence between demographically corrected 
scores and uncorrected test scores, they did mention that gender and education corrected 
scores showed slightly higher accuracy. More work needs to be done to determine the 
exact extent of the differences required to deem these small differences in findings as 
significant or non-significant. The future direction for research of this type should be to 
determine if this number translates into clinical significance at a population level.  
Previous work by Sliwinski and colleagues (1996; 1997) focused on a single 
memory test score, while later work by Hessler et al. (2014) used a heterogeneous 
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composite score that represented multiple cognitive domains. The current study deemed it 
unlikely that cognitive domains would be affected by demographic variables in a uniform 
manner. Thus, theoretical groupings of particular tests were used to represent different 
cognitive domains (memory, executive function, language, and attention). This allowed 
for a first-of-its-kind examination of how each domain was affected by demographic 
corrections. Raw memory composite score captured the most variation in the CDR-SB 
when standing alone, but when the other domains were added and the model was 
examined as a whole, the raw scores underperformed the models that included correction 
for education (See Table 11). The executive and language composite scores appeared to 
benefit the most from gender, age, and education correction. While the attention domain 
received a slight increase from age correction but captured the same amount of variability 
with all other norming methods. The differences did not fall into different effect size 
categories leaving some work to be done on how meaningful the findings are on a 
practical level.  
 
Table 10 











GEA 41.6% 5.0% 1% .1% 47.7% 
GA 41.7% 4.4% .9% .2% 47.1% 
GE 42.3% 4.6% .8% .1% 47.9% 
G 42.4% 4.1% .7% .1% 47.3% 
Note: n = 8724. Scores corrected for gender, education, and age (GEA). Scores corrected for 
gender, and age (GA). Scores corrected for gender, and education (GE). Raw scores (G) 






Hessler et al. (2014) determined that both corrected and uncorrected scores were 
highly significant predictors of progression to dementia even when adjusted for age and 
education but observed that education-corrected scores had slightly higher predictive 
accuracy. Their overall conclusion was that the differences between the models were 
small and did not reach a level of clinical significance, but acquiesced further 
investigation was necessary because of the limitations of their study. They questioned the 
generalizability of their study because their sample size was composed of a small set of 
inpatients (n = 537) who were recruited from 3 general hospitals. Once a patient is 
hospitalized, there is a greater chance that their performance on cognitive testing is 
compromised which may decrease the variability in the sample and mask clear results in 
the analysis. The current study improved on this by using a large data set that included 
individuals from across the Nation with a robust normal group, individuals classified as 
having normal cognition, as well as those with mild to moderate cognitive impairment 
and the same patterns were uncovered. The current study supported their conclusions, 
education corrected scores enhanced the relationship between the predictors and the 
outcome variable and age-corrected scores were the worst predictors of the outcome 
measure.  
In 2016 Quaranta et al. aimed to replicate the work of Hessler et al. (2014). 
Quaranta et al. (2016) failed to attain results that reached statistical significance and 
explicitly stated that their results did not clearly support age correction of test scores 
compromised their ability to predict progression to dementia, but acquiesced that, at least 
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theoretically, applying age norms in the diagnosis of MCI might partly decrease the 
prognostic value over the raw memory scores. Limitations cited by these authors included 
the recruitment of participants from general hospitals and not memory clinics, and also 
that the sample group was not homogeneous in etiology and included AD dementia, MD, 
and non-AD dementia. The current study addressed these limitations by using data from 
memory clinics and specified a primary diagnosis of AD dementia for inclusion criteria. 
A robust normal control group was also part of the current study design. The current 
study supported that age-corrected scores were inferior to raw scores and all other 
methods of demographic correction for capturing the amount of variability in the clinical 
dementia severity rating. A final thought on age correction, when revisiting the 
correlations between the cognitive composite test scores and one another, it appeared that 
even after scores were corrected for age and education, relationships still existed between 
the test scores and sample demographics. The strongest correlation was between the 
CDR-SB and age. It is common knowledge that the incidence of dementia increases with 
age, yet some may not consider the unintended consequence of age correcting test scores 
in an elderly population and removing the effects of a variable that is scientifically known 
to be correlated with dementia.  
Strengths and Limitations 
A strength of the present study is that it had a large amount of data utilizing the 
UDS-3NB, a standardized and clinically sound NP test battery endorsed by the National 
Alzheimer’s Coordinating Center. The inclusion criteria specified only AD etiology 
which addressed one of limitations cited by a previous researcher who recognized that 
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having multiple etiologies of dementia was a limitation because different types of 
dementia present with different NP profiles. It also screened out participants in advanced 
stages of dementia because again, their testing profiles would be highly variable and less 
reliable. Yet, this large data set with its robust normal control group may have also 
functioned as a limitation because the number of individuals with normal cognition far 
outnumbered those who were demented and this may have obscured larger effect size 
differences between the models and diluted the final interpretation of these differences. 
Another limitation of this study was the lack of universally accepted criteria for 
determining the incremental difference required to make a clinically significant 
contribution to clinical practice. When analyzing the significance of each individual 
predictors’ contribution to the overall models’ ability to capture meaningful variations in 
the CDR-SB score, the differences between the models were small and did not fall into 
different effect size categories leaving the final interpretation quite ambiguous. In the 
context of dementia evaluations, it can always be argued that any increase in R2 value 
leads to greater diagnostic accuracy and may be of practical significance at a population 
level. The recommendation for further research is determining how these differences 
translate at a population level, in other words what incremental increase confirms or 
disconfirms these findings as significant for clinical practice.  
Implications 
Improved diagnostic accuracy during the earliest stages of a neurodegenerative 
process is critically needed to move the field forward so disease-modifying interventions 
can succeed before too much irreversible damage is done (Ritchie et al., 2015; Sutphen et 
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al., 2015; Villemagne et al., 2012). Refinements in the science of cognitive testing that 
distinguish individuals who are experiencing the effects of normal aging from those in 
the process of developing neurodegenerative diseases gave rise to the question 
concerning the utility of raw scores versus demographically-corrected scores in norm-
referenced cognitive testing of an older population. The current study explored the 
strength of the relationship between tests scored different ways and dementia severity 
with the ultimate purpose of finding which way of scoring was most diagnostically 
accurate. Using a typical NP battery approach with composite test scores representing 
major cognitive domains affected by AD, demographic corrections for gender and 
education, leaving age correction out completely, constructed the most accurate model 
for predicting the dementia severity rating and highlighted that standard normative 
corrections may be insufficient for removing the confounding effects of age, gender, and 
education.  
Our ability to differentiate between normal cognitive aging and a 
neurodegenerative process earlier and with more accuracy has many implications for 
positive social change. If leaving out age correction increases the ability of testing to 
capture functional loss, it may allow for an earlier or more accurate diagnoses of a 
neurodegenerative process. This opens the window for the individual to earlier 
intervention, more time to provide evidence-based services that improve the individual’s 
quality of life. Drug interventions may slow the progression of the disease while 
cognitive rehabilitation can maximize reserved cognitive resources by teaching 
compensatory strategies. Behavioral interventions such as diet and exercise increase 
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quality of life and prolong a person’s independence. The individual also gains the benefit 
of participating in their own care and estate planning. Families benefit when they can 
develop and plan strategies to avoid disruption in employment, depletion of finances, and 
exacerbation of their own health issues from the emotional stress added by being a care 
giver. Society benefits because expenditures for an individual with dementia are 3 times 
the cost of care for people without dementia for the same age group causing a huge 
financial strain on our Medicare system. Delaying the onset of the disease for just one 
year saves resources on the costly and long course of this disease (AA, 2018; Dubois et 
al., 2016; Zissimopoulos et al., 2014).  
Conclusion 
 Dementia currently affects approximately 50 million people worldwide; a number 
that is projected to grow to 82 million by 2030 and 152 million by 2050. It is the second 
largest cause of disability for individuals aged 70 years and older, and the seventh leading 
cause of death. Dementia imposes an estimated economic cost of approximately US $818 
billion per year globally – or 1.1% of global gross domestic product. Left unaddressed, 
dementia could represent a significant barrier to social and economic development 
(WHO, 2018). Delaying the onset of the disease, even just for one year, has significant 
benefits (AA, 2018; Dubois et al., 2016; Hurd et al., 2013; Langa & Levine, 2014; 
Rockwood et al., 2014; Smith & Bondi, 2013; Sperling et al., 2011; Ward et al., 2013; 
Wei-Hong et al., 2017; Zissmopoulos et al., 2014). Any improvement in standardized 
testing is of value, even if it just detects one case of AD that might have gone 
undiagnosed. The results of the current study supported that best practice when 
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processing NP test scores in the service of a dementia diagnostic evaluation should 
include education correction. It can also be concluded that when we correct for age, we 
remove the effects of a variable that is systematically related to the outcome we are trying 
to predict simply because the incidence of AD increases with age. Clinicians need to 
consider this unintended consequence when utilizing test scores in the service of a 
dementia evaluation. Research focused on earlier and more accurate diagnoses is part of 
the formula leading to improvements in biomedical, psychological, and social 
interventions that have the potential to reduce the number of new cases by 10-20% and 
ease the physical, psychosocial, and financial hardships for individuals, their families, 
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Appendix: Histograms and Q – Q Plots from SPSS 
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